Trulieve Cannabis 株価情報 (OTC: TCNNF)

最新ニュース Trulieve Cannabis (OTC:TCNNF) 株価情報

Trulieve Cannabis

Trulieve Cannabis Corp is a vertically integrated seed to sale and fully licensed medical marijuana company. It is mainly engaged in the cultivation, possession, use, sale, and distribution of medical cannabis.

Cannabis

Earnings

News

Retail Sales

Markets

AAWH

AYRWF

CRLBF

CSE:TRUL

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

GTBIF

TCNNF

TRUL

VRNOF

2024年第2四半期の大部分の大麻企業の財務業績が出揃い、その結果から興味深いトレンドが浮かび上がってきた。その1つが、米国のマルチステート・オペレーター（MSO）が供給チェーンにおけるコストと効率を改善しているという点だ。

大麻関連企業の業績　供給チェーンにおけるコストと効率が改善

Analyst Color

Penny Stocks

Guidance

Emerging Markets

Small Cap

Analyst Ratings

Trading Ideas

CCHWF

令は効率的な運営者の市場占有率の増加と持続可能なプラットフォーム構築を輝かせるだろう。第２四半期の収益を見越して、Zuanic &amp; Associatesのシニアアナリスト、Pablo Zuanic氏は、大麻市場傾向について概要を提供した。

大麻ブームか不況か　正念場の大麻市場

Government

Regulations

Politics

General

CNBS

JUSHI HLDGS INC CL B by Jushi Holdings Inc.

JUSHF

TILT

ペンシルベニア州が最近承認した予算には、大麻企業であるJushi Holdings（OTC：JUSHF）およびTILT Holdings（OTC：TILT）のような企業にとって大きな打撃を与える、大麻の娯楽利用の合法化が除外されています。

ペンシルベニア州　大麻の娯楽利用合法化に制限掲示へ

TRULIEVE CANNABIS CORP by Trulieve Cannabis Corporation

Trulieve Cannabis Corp

Trulieve Cannabis Corp. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>) filed a defamation lawsuit on Wednesday, accusing the Florida Republican Party of intentionally misleading voters with a deceptive TV campaign ad against the cannabis legalization initiative, known as <a href="https://www.benzinga.com/markets/cannabis/24/04/38034138/florida-supreme-court-approves-cannabis-legalization-proposal-for-november-election-in-blow-to-d" target="_blank" rel="noreferrer noopener">Amendment 3</a> that will go before the voters this coming <a href="https://www.benzinga.com/topic/2024-election" target="_blank" rel="noreferrer noopener">November</a>. 
The lawsuit alleges that the ad misleads voters by falsely implying that only large cannabis companies, like Trulieve will benefit from the legalization measure, while ordinary Floridians would be prohibited from growing their own marijuana.
The ad features a gardener apparently excited by the news of marijuana legalization but is then interrupted by a character called &#8220;Big Weed,&#8221; who claims that only large corporations can legally grow cannabis under the proposed amendment.
Trulieve's legal team argues that the &#8220;Big Weed&#8221; character is a clear reference to their company, Florida's largest medical marijuana operator, which has <a href="https://www.benzinga.com/markets/cannabis/24/08/40486924/ken-griffins-12m-donation-and-desantiss-anti-cannabis-pacs-face-off-against-pro-legalization-gro">contributed more than $90 million</a> to the cannabis legalization campaign. The lawsuit contends that this narrative is not only false but strategically designed to deceive voters into believing that Amendment 3 would create a monopoly for already established cannabis companies.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/10/41149545/trump-harris-vance-and-walz-agree-on-this-end-cannabis-criminalization-in-florida">Trump, Harris, Vance And Walz Agree On This: End Cannabis Criminalization In Florida</a>
<h3 class="wp-block-heading">Home Cultivation Controversy</h3>
The issue of home cultivation <a href="https://www.benzinga.com/markets/cannabis/24/08/40496563/ron-desantis-staffer-peeved-flordias-cannabis-legalization-initiative-has-no-home-grow-provision">has become a point of contention</a> in the debate over Amendment 3. Opponents say the amendment will solidify the dominance of the state's licensed medical marijuana operators like Trulieve by allowing them to control the recreational weed market.
However, Trulieve's lawsuit contends that the proposed amendment does not address nor change the existing ban on home cultivation of marijuana. According to the company, the controversial TV ad falsely suggests otherwise.
<h3 class="wp-block-heading">DeSantis And Florida GOP On The War Path</h3>
The lawsuit also highlights a mailer distributed by the Republican Party of Florida, which accuses "mega marijuana corporations" of orchestrating a &#8220;power grab&#8221; to eliminate competition and cement their monopoly. 
Florida Governor Ron DeSantis (R) <a href="https://www.benzinga.com/markets/cannabis/24/08/40642418/florida-cannabis-legalization-gains-momentum-64-of-likely-voters-support-amendment">has claimed that Trulieve authored</a> the amendment and is creating a "de facto monopoly&#8221; and &#8220;weed cartel.&#8221;
Trulieve's lawyers assert, <a href="https://www.miamiherald.com/news/politics-government/state-politics/article293383819.html">according</a> to the Miami Herald, that this claim is equally misleading, and that the amendment would actually enable the state Legislature to expand the number of licensed marijuana operators, thereby increasing competition in the market.
<h3 class="wp-block-heading">GOP: Lawsuit Is &#8216;Overreaction&#8217;</h3>
Republican Party of Florida representative Anthony Power dismissed the lawsuit as an overreaction. "It's funny that a company that spends almost $100 million on a political campaign is so sensitive about honest TV ads," Power said in a statement, per the outlet. He characterized the lawsuit as an attempt to silence critics and vowed to continue opposing the measure.
In filing the lawsuit, Trulieve said it is seeking "to set the record straight, to vindicate its rights under civil law, to hold the defendants accountable for deceiving voters, and to recover compensatory and punitive damages."  
With voting by mail already underway in Florida, this will surely be an ongoing story, so stay tuned.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/09/41036799/desantis-provokes-outrage-over-taxpayer-funded-ads-linking-marijuana-legalization-to-car-crashes">DeSantis Provokes Outrage Over Taxpayer-Funded Ads Linking Marijuana Legalization To Car Crashes</a></li>
</ul>

Legal

Trulieve Sues Florida GOP For Defamation Over 'False And Misleading' Claims As Cannabis Legalization Vote Looms

Despite pouring millions into the push for adult-use cannabis legalization, Florida's cannabis market is showing signs of strain.&nbsp;
According to a recent report from <a href="https://www.benzinga.com/topic/beacon-securities-limited">Beacon Securities</a>, financial backing for the legalization campaign has surged, yet dispensary sales have slipped during the third quarter of 2024.&nbsp;
Companies like Trulieve Cannabis Corp. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>) and Curaleaf Holdings Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>) are leading the charge with significant contributions, but the growing number of dispensaries and external factors, such as Hurricane Helene, have raised questions about whether the market's fundamentals justify the hype.
<ul>
<li>Get Benzinga&#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. You can't afford to miss out if you&#8217;re serious about the business.</li>
</ul>
<h3 class="wp-block-heading">Turbocharged</h3>
The <a href="https://www.benzinga.com/markets/cannabis/24/09/41036799/desantis-provokes-outrage-over-taxpayer-funded-ads-linking-marijuana-legalization-to-car-crashes">Smart &amp; Safe Florida </a>campaign, responsible for spearheading the adult-use legalization efforts, received a significant financial push in September.&nbsp;
According to the report by analysts Doug Cooper, Russell Stanley and Donangelo Volpe, Trulieve Cannabis recently added $9.5 million to its contributions, while Curaleaf contributed $1 million. To date, the campaign has raised over $100 million, with more than $24 million still available. 
<h3 class="wp-block-heading">Diluted Growth</h3>
Per-dispensary sales in <a href="https://www.benzinga.com/markets/cannabis/24/09/41002710/your-cousins-in-florida-like-their-weed-why-hispanic-voters-could-tip-the-scale-for-cannabis-wil">Florida</a> showed signs of softening during Q3, impacted by an increasing number of dispensaries and temporary disruptions like Hurricane Helene.&nbsp;
The state saw a 4% quarter-over-quarter (q/q) rise in dispensaries, with nine companies adding a total of 26 new locations.&nbsp;
According to the report, Trulieve alone accounted for 12 of these openings.&nbsp;
Overall, flower sales volume in the state increased 3% q/q, while oil-based product sales dipped 1%, with both categories showing slower growth compared to the previous quarter.
On a per-dispensary basis, flower sales volumes slipped 1% q/q, while oil-based product sales fell 5%.&nbsp;
These figures likely reflect the increased competition from <a href="https://www.benzinga.com/markets/cannabis/24/09/40990665/cannabis-sales-bloom-in-first-north-carolina-weed-store-marijuana-footprint-in-florida-grows-as-">new dispensaries</a> and effect of storm-related closures.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/09/40774795/trump-says-hell-reschedule-cannabis-if-elected-backs-marijuana-banking-reform-and-floridas-amend">Trump Says He&#8217;ll Reschedule Cannabis If Elected, Backs Marijuana Banking Reform And Florida&#8217;s Amendment</a>
<h3 class="wp-block-heading">Top Players See Mixed Results&nbsp;</h3>
Trulieve, the dominant player in <a href="https://www.benzinga.com/markets/cannabis/24/09/40969689/desantis-urges-gop-to-oppose-cannabis-legalization-as-party-splits-over-trump-marijuana-endorsem">Florida</a>, maintained its leadership position despite mixed results in both product categories. Its flower sales increased by 1% q/q, although the company lost 68 basis points (bps) in market share, now standing at 38%. In the oil-based product category, Trulieve&#8217;s sales remained flat, but it gained 50 bps in market share, increasing its lead to 31%.
Curaleaf, the second-largest operator in Florida, reported a strong 11% rise in flower sales volumes, boosting its market share by 79 bps to 10%. However, its oil-based product sales fell 2%, though it retained its second-place ranking with a 13% market share despite a slight loss of share.
Verano Holdings Corp. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/VRNOF#OTC">VRNOF</a>) had flat flower sales following sequential declines in Q1 and Q2, which were attributed to capacity upgrades. The company's market share in flower sales slipped by 19 bps, landing at 7%, keeping its third-place ranking. Verano's oil-based product sales dropped 8%, reducing its share by 68 bps to 9%.
Ayr Wellness Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/AYRWF#OTC">AYRWF</a>) experienced strong growth in flower sales, up 12% q/q, which increased its <a href="https://www.benzinga.com/markets/cannabis/24/09/40753011/ayr-wellness-conditional-approval-for-medical-marijuana-operations-in-virginia-what-it-means-for">market share</a> by 51 bps to over 6%, ranking fourth in the state. However, its oil-based product sales declined 7%, dropping its share by 72 bps, though it maintained its third-place position with a 12% market share.
<h3 class="wp-block-heading">Smaller Players </h3>
<ul>
<li>Cresco Labs Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>) saw solid growth in both product categories, with flower sales volumes rising 7% q/q, raising its market share by 20 bps to 5%. The company&#8217;s oil-based product sales increased 6%, adding 23 bps in market share, taking it up to 4%.</li>
</ul>
<ul>
<li>Green Thumb Industries Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTC">GTBIF</a>) posted mixed results, with flower sales declining by 18% q/q, lowering its market share by 45 bps to 2%. However, its oil-based product sales surged by 26%, adding 48 bps to its market share, also reaching 2%.</li>
</ul>
<ul>
<li>Planet 13 Holdings Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/PLNHF#OTC">PLNHF</a>) managed to hold its ground in the oil-based products segment, with market share flat at 2% despite a 2% sales decline. However, the company's flower sales fell 12%, reducing its market share by 47 bps to just under 3%.</li>
</ul>
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/09/40712816/what-trump-learned-about-marijuana-that-desantis-did-not-and-why-the-gop-might-become-weed-frien">What Trump Learned About Marijuana That DeSantis Did Not And Why The GOP Might Become Weed-Friendly</a>
<h3 class="wp-block-heading">Florida's $100M Bet: What's At Stake</h3>
With adult-use cannabis legalization on the horizon through Amendment 3, Florida's market is set to see significant changes. According to <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38470560/landing-in-floridas-cannabis-market-legal-adult-use-marijuana-could-yield-874m-in-2">BDSA data</a>, total cannabis sales in Florida are projected to grow at a 12% compound annual growth rate (CAGR) from 2023 to 2028, reaching $4.5 billion by the end of that period.
However, legislative uncertainties surrounding the expansion of adult-use licenses add unpredictability to the market, with over 600 dispensaries already in operation and medical cannabis sales hitting $2.6 billion in 2023.
<h3 class="wp-block-heading">Hype-Worthy?</h3>
Pablo Zuanic&#8216;s analysis paints an optimistic picture for Florida's cannabis market, predicting a $6 billion valuation and significant growth for operators like Cansortium and AYR Wellness<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38037571/floridas-6b-cannabis-market-anticipates-400-growth-following-court-decision-allowin"> if adult-use legalization passes in November 2024</a>.&nbsp;
Zuanic forecasts up to 400% growth for AYR and substantial upside for other major players, highlighting the potential market explosion. However, when compared to the recent Beacon Securities report, which shows slipping per-dispensary sales and slowing growth, the question remains whether the market fundamentals can sustain this anticipated boom.&nbsp;
Read Next: <a href="https://www.benzinga.com/markets/cannabis/24/09/40879364/young-republicans-break-ranks-to-back-cannabis-legalization-is-the-gop-ready-for-a-shift-in-the-">Young Republicans Break Ranks To Back Cannabis Legalization &#8211; Is The GOP Ready For A Shift In The Status Quo?</a>

Market Summary

Economics

PLNHF

Slipping Weed Sales In Florida's Market: Is This $100M Bet Really Worth The Hype?

Trulieve Cannabis Corp. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/TRUL#CSE">TRUL</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTCQX">TCNNF</a>) announced Tuesday that it has entered into a partnership with Black Buddha Cannabis.
The collaboration will debut products from women-owned medical marijuana brands to Trulieve dispensaries in Arizona and Pennsylvania starting this fall.
Products from Black Buddha&#8217;s &#8220;BLYSS&#8221; and &#8220;DREAM&#8221; lines of premium medical marijuana flower will be available in Trulieve stores throughout the two states starting Friday, Oct. 4.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/cannabis-conference/"><img loading="lazy" decoding="async" width="970" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/01093122/ccc-oct-24-banner__1_-1.gif" alt="" class="wp-image-574647" /></a></figure>
Founded by Roz McCarthy, CEO of Soaring High Industries and Minorities for Medical Marijuana, Black Buddha Cannabis "brings a unique approach to the medical marijuana industry with a focus on wellness and healing."
Read Also: <a href="https://www.benzinga.com/markets/cannabis/22/02/25348968/redefining-black-owned-weed-minorities-for-medical-marijuana-m4mm-s-roz-mccarthy-launches-black-">Redefining Black-Owned Weed: Minorities For Medical Marijuana (M4MM)&#8217;s Roz McCarthy Launches Black Buddha Cannabis</a>
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.</li>
</ul>
&#8220;We are incredibly excited to bring Black Buddha Cannabis to the vibrant markets of Arizona and Pennsylvania,&#8221; McCarthy said in a press release. &#8220;Our brand is deeply rooted in wellness, and our mission is to help people feel better, whether they are part of the adult-use or medical marijuana community. We believe everyone deserves access to products that enhance their well-being, and we&#8217;re thrilled to offer our carefully curated flower lines to these new markets.&#8221;
Kim Rivers, Trulieve&#8217;s CEO, shared McCarthy's enthusiasm.
&#8220;We are excited to welcome Black Buddha Cannabis to our product lineup,&#8221; Rivers said. &#8220;Roz&#8217;s inspiring story and her brand&#8217;s dedication to healing through medical marijuana align perfectly with Trulieve&#8217;s mission to provide high-quality, purpose-driven products to our customers.&#8221;
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/22/09/28857745/exclusive-trulieve-ceo-kim-rivers-calls-to-action-on-cannabis-reform">EXCLUSIVE: Trulieve CEO Kim Rivers&#8217; Calls To Action On Cannabis Reform</a></li>
</ul>

Medical Cannabis Giant Trulieve Partners With Black Buddha To Launch New Marijuana Flower Lines In Arizona And Pennsylvania

<a href="https://www.benzinga.com/events/cannabis-conference/">Ross Gerber</a>, co-founder and CEO of Gerber Kawasaki Wealth and Investment Management, is set to take the stage at this year's <a href="https://www.benzinga.com/events/cannabis-conference/">Benzinga Cannabis Capital Conference</a> in Chicago on October 8-9, 2024. Known for his bold views on the <a href="https://www.benzinga.com/cannabis">cannabis industry</a> and keen insight into finance, Gerber's appearance at the event provides attendees an opportunity to hear from one of the leading voices on <a href="https://www.benzinga.com/events/cannabis-conference/">the intersection of cannabis and capital markets</a>.
<h3 class="wp-block-heading">Leader In Cannabis Finance And Long-Time Legalization Advocate</h3>
Gerber's influence in the financial world is well-established. His Santa Monica-based firm, Gerber Kawasaki, managed more than $2.6 billion in assets as of January, 2024. But what sets him apart is his longstanding advocacy for cannabis legalization, a passion that dates back to his college years at the University of Pennsylvania, where he organized one of the largest pro-legalization rallies on campus.
Over the years, Gerber has cultivated close ties with industry heavyweights like Trulieve (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>)'s Kim Rivers, TerrAscend (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TSNDF#OTC">TSNDF</a>)'s Jason Wild, and Ben Kovler of Green Thumb Industries (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTC">GTBIF</a>), using his platform to advance the conversation around cannabis reform. Gerber&#8217;s investments and advocacy in the cannabis space have made him a key figure in discussions about the future of cannabis finance, particularly in the context of potential federal rescheduling.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="The Big Cannabis Show" width="500" height="281" src="https://www.youtube.com/embed/XgZ2aVcoaug?start=27&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
<h3 class="wp-block-heading">What To Expect From The Benzinga Cannabis Capital Conference</h3>
At the <a href="https://www.benzinga.com/events/cannabis-conference/">Benzinga Cannabis Capital Conference</a>, Gerber will bring his candid insights on the challenges cannabis businesses face, from tax issues to limited access to capital. As someone who has long advocated for cannabis rescheduling, he'll dive into the potential shifts this could bring to the industry.
In recent discussions, Gerber noted that federal rescheduling could relieve cannabis companies from burdensome tax laws and open doors for mainstream financial institutions to participate in the market. "The financial performance of cannabis companies could improve dramatically with even small changes to federal law," he said in previous talks.
Attendees can also expect Gerber to shed light on the importance of leadership and innovation in navigating these turbulent waters. His partnerships with CEOs like Rivers and Wild have only reinforced his belief that strategic vision will determine who thrives as the industry faces upcoming legal changes.
<h3 class="wp-block-heading">A Must-Attend Event For Cannabis Investors And Industry Participants</h3>
With over 2,000 attendees and 200-plus investors slated to attend, this year's <a href="https://www.benzinga.com/events/cannabis-conference/">Benzinga Cannabis Capital Conference</a> is expected to be one of the most significant gatherings in the industry. Whether you're a seasoned investor or new to the cannabis game, Gerber's talk promises to provide critical insights into where the industry is heading and how to position yourself for success.
Gerber's participation isn't just about what's happening now, it's about what comes next. His focus on the financial mechanisms that can reshape the cannabis landscape offers investors and industry insiders alike a roadmap for navigating the opportunities ahead.
<h3 class="wp-block-heading">Don't Miss Out</h3>
If cannabis finance and investment are on your radar, you won't want to miss this chance to <a href="https://www.benzinga.com/events/cannabis-conference/">hear from Ross Gerber</a>. With early bird tickets now available, it's the perfect time to <a href="https://www.benzinga.com/events/cannabis-conference/">secure your spot</a> at the <a href="https://www.benzinga.com/events/cannabis-conference/">Benzinga Cannabis Capital Conference</a> and be part of the conversation shaping the future of cannabis.

Events

TSNDF

Multi-Billion-Dollar Fund Manager Ross Gerber Will Discuss Cannabis And Its Financial Future At This Key Chicago Event

As Tropical Storm Helene intensifies and approaches Florida's Gulf Coast, Trulieve Cannabis Corp (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>), one of the largest multi-state operators (MSOs) in the U.S. weed industry, is bracing for potential disruptions. Investors have voiced concerns about the storm's potential impact on operations, especially given Trulieve's extensive footprint in Florida. However, Trulieve&#8217;s CEO Kim Rivers says the company is fully prepared for what's coming ashore.
In a Twitter exchange responding to user @WolfOfWeedST, Rivers laid out the company's readiness plans, noting that it&#8217;s facilities are built to withstand the storm. &#8220;We are locked and loaded. Not our first storm rodeo. Buildings are all wind rated and have all been thru storms in the past,&#8221; Rivers wrote, addressing concerns about infrastructure vulnerabilities as Helene strengthens into a potentially catastrophic event.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">We are locked and loaded. Not our first storm rodeo. Buildings are all wind rated and have all been thru storms in the past. The biggest threat is loss of power but lines come from the southeast so that's looking ok. Regardless, generators are on site, storm prep done and teams…
&mdash; Kim Rivers (@rivers_kim) <a href="https://twitter.com/rivers_kim/status/1838931491704721750?ref_src=twsrc%5Etfw">September 25, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
<h3 class="wp-block-heading">A Storm On The Horizon</h3>
Helene, which is expected to make landfall as a major hurricane, poses a significant threat to Florida's west coast. The National Hurricane Center (NHC) has already issued warnings for storm surges that could reach up to 15 feet, along with wind speeds forecasted to exceed 100 mph as the storm intensifies. Counties along the Florida coast have begun issuing evacuation orders and power outages are expected.
Trulieve's headquarters, operations and dispensaries are heavily concentrated in Florida, making the company particularly vulnerable to disruptions. But Rivers assured stakeholders that the company's hurricane preparedness plan has been activated. While acknowledging that the biggest challenge could be power outages, she remained optimistic. "The biggest threat is loss of power but lines come from the southeast so that's looking ok. Regardless, generators are on site, storm prep done and teams ready to go."
<h3 class="wp-block-heading">Impact On Cannabis Supply Chain</h3>
Given that Trulieve also supplies wholesale cannabis products to other operators, any disruption to its facilities could ripple throughout the supply chain.
Cannabis investors are watching closely, with some expressing concern over potential setbacks to the cannabis industry's recovery after a challenging several years. @WolfOfWeedST pointed out, "The only thing that can screw up A3 [Amendment 3, the initiative to legalize adult-use cannabis in the state] and this run is hurricane Helene for the MSO's in Florida," highlighting the dependency of several players on Trulieve's production and wholesale operations.
As the cannabis industry watches closely, Helene's path will be a key focus in the coming days. While the physical infrastructure is in place, the true test will come in the aftermath of the storm, when the focus will shift to how quickly operations can resume and whether supply chains remain intact.
Here&#8217;s hoping everyone remains safe and sound.

Will Hurricane Helene Disrupt Florida's Cannabis Industry? Trulieve CEO Says Co. Is 'Locked And Loaded, Not Our First Storm Rodeo'

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/FUAPF">Global Compliance</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FUAPF#OTC">FUAPF</a>) shares closed up 43.83% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CNGGF">Cann Gr</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNGGF#OTC">CNGGF</a>) shares closed up 26.80% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed up 25.00% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/LMLLF">Pharmadrug</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LMLLF#OTC">LMLLF</a>) shares closed up 17.17% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/MGWFF">Maple Leaf Green World</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MGWFF#OTC">MGWFF</a>) shares closed up 12.70% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/MXC">Mexco Energy</a> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MXC#AMEX">MXC</a>) shares closed up 6.21% at $13.69</li>
<li><a href="https://www.benzinga.com/quote/YCBD">cbdMD</a> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) shares closed up 5.32% at $0.48</li>
<li><a href="https://www.benzinga.com/quote/CXXIF">C21 Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CXXIF#OTC">CXXIF</a>) shares closed up 5.31% at $0.25</li>
<li><a href="https://www.benzinga.com/quote/BMMJ">Body and Mind</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BMMJ#OTC">BMMJ</a>) shares closed up 5.28% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/GNLN">Greenlane Hldgs</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares closed up 4.78% at $5.24</li>
<li><a href="https://www.benzinga.com/quote/CNPOF">RIV Capital</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNPOF#OTC">CNPOF</a>) shares closed up 4.52% at $0.17</li>
<li><a href="https://www.benzinga.com/quote/GRWG">GrowGeneration</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>) shares closed up 4.50% at $2.09</li>
<li><a href="https://www.benzinga.com/quote/SMG">Scotts Miracle Gro</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>) shares closed up 4.22% at $81.21</li>
<li><a href="https://www.benzinga.com/quote/OILFF">Nextleaf Solutions</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OILFF#OTC">OILFF</a>) shares closed up 3.93% at $0.07</li>
<li><a href="https://www.benzinga.com/quote/TCNNF">Trulieve Cannabis</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>) shares closed up 3.81% at $11.98</li>
<li><a href="https://www.benzinga.com/quote/ZDPY">Zoned Props</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ZDPY#OTC">ZDPY</a>) shares closed up 3.50% at $0.59</li>
<li><a href="https://www.benzinga.com/quote/XXII">22nd Century Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) shares closed up 3.19% at $0.28</li>
<li><a href="https://www.benzinga.com/quote/VFF">Village Farms Intl</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) shares closed up 3.15% at $0.91</li>
<li><a href="https://www.benzinga.com/quote/ACB">Aurora Cannabis</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) shares closed up 3.03% at $5.74</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/GBHPF">Global Hemp Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GBHPF#OTC">GBHPF</a>) shares closed down 13.74% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed down 10.00% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed down 9.27% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CARA">Cara Therapeutics</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARA#NASDAQ">CARA</a>) shares closed down 8.64% at $0.28</li>
<li><a href="https://www.benzinga.com/quote/CLSH">CLS Holdings USA</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CLSH#OTC">CLSH</a>) shares closed down 8.51% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/CBDY">Target Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBDY#OTC">CBDY</a>) shares closed down 8.18% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CNTMF">Cansortium</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNTMF#OTC">CNTMF</a>) shares closed down 8.18% at $0.15</li>
<li><a href="https://www.benzinga.com/quote/ELLXF">Elixinol Wellness</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ELLXF#OTC">ELLXF</a>) shares closed down 6.98% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CVSI">CV Sciences</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CVSI#OTC">CVSI</a>) shares closed down 4.74% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/BBRRF">Blueberries Medical</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BBRRF#OTC">BBRRF</a>) shares closed down 3.85% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CURR">Currenc Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CURR#NASDAQ">CURR</a>) shares closed down 3.57% at $2.70</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

BBRRF

BMMJ

CARA

CBDY

CLSH

CNGGF

CNPOF

CNTMF

CURE PHARMA HLDG CORP by CURE Pharmaceutical Holding Corp.

CURR

CVSI

CXXIF

ELLXF

FUAPF

GBHPF

GNLN

GRWG

LEAFBUYER TECHNOLOGIES by Leafbuyer Technologies, Inc.

LBUY

LMLLF

MGWFF

OILFF

RMHB

TGIFF

XXII

YCBD

ZDPY

Cannabis Stock Gainers And Losers From September 24, 2024

Hispanics, who account for 22% of Florida's electorate with 2.75 million voters, are showing increasing support for cannabis legalization. In a recent poll conducted by TelevisaUnivision and Media Predict, 60% of Hispanic voters in the state expressed either a definite or probable &#8220;yes&#8221; on Amendment 3, which seeks to legalize recreational cannabis for adults aged 21 and older.&nbsp;
This is a 2% rise from last month's numbers, highlighting growing acceptance within this key demographic. For cannabis investors, this trend signals potential market expansion in Florida, making the Hispanic electorate an essential group to watch as it could shape the future of the state's cannabis industry.
<ul>
<li>Get Benzinga&#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. You can't afford to miss out if you&#8217;re serious about the business.</li>
</ul>
<h3 class="wp-block-heading">High Support Among Non-Hispanic Voters</h3>
Among non-Hispanic voters, 63% showed similar enthusiasm for cannabis legalization. The <a href="https://uci.sharepoint.com/:p:/s/KWTeam/Eeh7819q-VhCkaX-fpsvOVsBQMO7sxoSN1b2BpFw3fbzdA?rtime=JcOK8MDY3Eg">poll</a>, conducted online from September 12-16 with 1,155 likely voters, highlights the growing acceptance of recreational cannabis across diverse voter groups. Investors should take note: if approved in the November election, <a href="https://www.benzinga.com/topic/florida-cannabis">Florida&#8217;s cannabis market</a> could undergo a <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38037571/floridas-6b-cannabis-market-anticipates-400-growth-following-court-decision-allowin">400% growth</a>, providing new opportunities for business development.
<h3 class="wp-block-heading">Economic Concerns Remain Paramount</h3>
In addition to cannabis, Florida Politics <a href="https://floridapolitics.com/archives/697038-poll-hispanic-voters-are-warming-to-florida-ballot-measures-on-recreational-pot-abortion/">reported</a> that abortion rights have also captured the attention of Hispanic voters. Amendment 4, which seeks to protect abortion access until fetal viability (around 24 weeks), had consistent support from 63% of Hispanic voters. The intensity of this support grew, with 41% now expressing certainty in their vote, up from 39% last month.
While cannabis and abortion are hot topics, economic issues remain at the top of the list for Hispanic voters. A staggering 80% of respondents identified the rising cost of living as the most pressing issue, followed by inflation at 79%.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/09/40879364/young-republicans-break-ranks-to-back-cannabis-legalization-is-the-gop-ready-for-a-shift-in-the-">Young Republicans Break Ranks To Back Cannabis Legalization—Is The GOP Ready For A Shift In The Status Quo?</a>
<h3 class="wp-block-heading">Will It Be Enough?</h3>
As Florida and the natioin approach the upcoming <a href="https://www.benzinga.com/topic/2024-election">November 2024 elections,</a> the outcome remains uncertain. National dynamics, such as concerns over the economy and immigration, may overshadow cannabis reform as a top priority for voters. 
While V.P. Kamala Harris and her running mate <a href="https://www.benzinga.com/general/politics/24/09/40844701/trump-harris-might-not-debate-again-but-their-running-mates-will-what-voters-should-know-about-w">Tim Walz </a>support <a href="https://www.benzinga.com/markets/cannabis/24/09/40846480/cannabis-experts-say-weed-reform-is-a-race-against-time-is-the-dea-delaying-bidens-rescheduling-">federal cannabis reform</a>, Donald Trump&#8216;s recent <a href="https://www.benzinga.com/markets/cannabis/24/08/40666944/donald-trump-supports-cannabis-legalization-in-florida-game-changer-and-huge-blow-to-ron-desanti">backing </a>for legalization in Florida presents a different challenge. His stance is more of a concept rather than a detailed policy.
Trump's endorsement could energize conservative voters who may previously have been ambivalent on the issue, potentially undercutting Harris's advantage in traditionally progressive areas.&nbsp;
Despite strong support for Amendment 3 among Hispanic voters, the broader electorate's focus on economic and social issues in such a divided political landscape may limit its impact on swaying the cannabis legalization effort.
Trulieve Cannabis Corp. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>), Curaleaf Holdings, Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>), and Ayr Wellness Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/AYRWF#OTC">AYRWF</a>) are some of the<a href="https://www.benzinga.com/cannabis"> key players</a> in Florida's medical cannabis market. Trulieve, in particular, dominates the Florida market with a large number of dispensaries. If Amendment 3 passes, these companies could see significant stock movement as they transition to serving a broader, recreational consumer base.
Read Next: <a href="https://www.benzinga.com/markets/cannabis/24/09/40926862/desantis-targets-one-big-weed-company-funding-floridas-legalization-campaign-cites-corporate-int">DeSantis Targets &#8216;One Big Weed Company&#8217; Funding Florida&#8217;s Legalization Campaign, Citing &#8216;Corporate Interests&#8217;</a>

Your Cousins In Florida Like Their Weed: Why Hispanic Voters Could Tip The Scale For Cannabis,Will It Be Enough?

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed up 33.33% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/MGWFF">Maple Leaf Green World</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MGWFF#OTC">MGWFF</a>) shares closed up 29.66% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed up 25.65% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/NWVCF">EnWave</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed up 14.84% at $0.17</li>
<li><a href="https://www.benzinga.com/quote/ITHUF">iAnthus Capital Hldgs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ITHUF#OTC">ITHUF</a>) shares closed up 13.39% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/RSSFF">Affinor Growers</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RSSFF#OTC">RSSFF</a>) shares closed up 13.21% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed up 12.58% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/ELLXF">Elixinol Wellness</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ELLXF#OTC">ELLXF</a>) shares closed up 11.48% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed up 11.11% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/XXII">22nd Century Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) shares closed up 10.73% at $0.29</li>
<li><a href="https://www.benzinga.com/quote/CBDY">Target Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBDY#OTC">CBDY</a>) shares closed up 10.00% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CXXIF">C21 Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CXXIF#OTC">CXXIF</a>) shares closed up 7.91% at $0.24</li>
<li><a href="https://www.benzinga.com/quote/CVSI">CV Sciences</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CVSI#OTC">CVSI</a>) shares closed up 6.49% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/SMG">Scotts Miracle Gro</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>) shares closed up 5.47% at $77.92</li>
<li><a href="https://www.benzinga.com/quote/EAST">Eastside Distilling</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EAST#NASDAQ">EAST</a>) shares closed up 5.14% at $0.49</li>
<li><a href="https://www.benzinga.com/quote/MRMD">MariMed</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MRMD#OTC">MRMD</a>) shares closed up 4.69% at $0.17</li>
<li><a href="https://www.benzinga.com/quote/TCNNF">Trulieve Cannabis</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>) shares closed up 4.53% at $11.54</li>
<li><a href="https://www.benzinga.com/quote/CRLBF">Cresco Labs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>) shares closed up 4.37% at $1.67</li>
<li><a href="https://www.benzinga.com/quote/VFF">Village Farms Intl</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) shares closed up 3.55% at $0.91</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/FUAPF">Global Compliance</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FUAPF#OTC">FUAPF</a>) shares closed down 33.33% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/SOLCF">SOL Glb Inv</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SOLCF#OTC">SOLCF</a>) shares closed down 14.08% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/KAYS">Kaya Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/KAYS#OTC">KAYS</a>) shares closed down 9.42% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/CURR">Currenc Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CURR#NASDAQ">CURR</a>) shares closed down 7.12% at $2.80</li>
<li><a href="https://www.benzinga.com/quote/OILFF">Nextleaf Solutions</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OILFF#OTC">OILFF</a>) shares closed down 5.87% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/CNPOF">RIV Capital</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNPOF#OTC">CNPOF</a>) shares closed down 5.45% at $0.16</li>
<li><a href="https://www.benzinga.com/quote/CNBX">CNBX Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed down 4.23% at $0.01</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CNBX

EAST

FFNTF

ITHUF

KAYS

MRMD

NWVCF

RSSFF

SOLCF

Bullish Sentiment Across The Cannabis Space - Check Full Movers For September 23, 2024

<h3 class="wp-block-heading">Thousands Are Buying Weed In North Carolina's Only Weed Shop</h3>
Cannabis sales are booming in North Carolina's only legal store selling recreational marijuana. Great Smoky, located on the 57,000-acre Qualla Boundary of the Eastern Band of Cherokee Indians (EBCI,) has been serving all adults 21 and older for a couple of weeks.
The shop at 91 Bingo Loop Road in Cherokee, Swain County, has been selling recreational marijuana as of Saturday, Sept. 7, only to see thousands of customers making cannabis purchases, <a href="https://www.marijuanamoment.net/thousands-flock-to-tribal-marijuana-store-in-north-carolina-where-cannabis-is-otherwise-illegal-for-launch-of-adult-use-sales/">reported</a> Marijuana Moment.
Forrest Parker, general manager for Qualla Enterprises, which operates Great Smoky Cannabis Co., <a href="https://theonefeather.com/2024/09/07/cherokee-begins-sales-of-adult-use-21-cannabis-for-all/">told</a> Cherokee One Feather it's "validating" to see people standing in line to get their cannabis products.
<h3 class="wp-block-heading">Four News Cannabis Stores Open In Florida Amid Marijuana Legalization Debate</h3>
Meanwhile, in Florida, medical cannabis giant Trulieve Cannabis Corp. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/TRUL#CSE">TRUL</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTCQX">TCNNF</a>) revealed that it will be hosting grand opening celebrations at two new stores on Friday, Sept. 27.
Trulieve Lake Worth Hypoluxo is located at 4660 Hypoluxo Road; Trulieve Hudson at 11909 State Road 52. Both locations will carry a variety of products including Trulieve&#8217;s portfolio of in-house brands such as Alchemy, Co2lors, Cultivar Collection, Modern Flower, Momenta, Muse, Roll One, Sweet Talk, and Trekkers. 
Customers will also have access to the company's partner brands: Alien Labs, Bellamy Brothers, Binske, Black Tuna, Blue River, Connected Cannabis, DeLisioso, Khalifa Kush, Love&#8217;s Oven, Miami Mango, O.pen, Seed Junky and Sunshine Cannabis.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/cannabis-conference/"><img loading="lazy" decoding="async" width="970" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/23154706/ccc-oct-24-banner__1_-35.gif" alt="" class="wp-image-561862" /></a></figure>
RISE Dispensaries, a cannabis retail chain owned by Green Thumb Industries Inc. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/GTII#CSE">GTII</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTCQX">GTBIF</a>) opened its newest location, RISE Jacksonville, on Friday, Sept. 13. 
Located at 9421 Baymeadows Road, the dispensary marked the 20th RISE location in the Sunshine State and the 98th nationwide.
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out</li>
</ul>
Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/VRNOF#OTCQX">VRNOF</a>) kicked off sales at MÜV Melbourne and MÜV Okeechobee on Friday, Sept. 13. 
The company raised its retail footprint to 79 Florida dispensaries and 152 retail locations nationwide. 
MÜV Melbourne, located at 7660 N Wickham Road, and MÜV Okeechobee, located at 510 NE Park Street feature online menus for browsing their extensive product selection, including the company's signature Verano Reserve, MÜV and Sweet Supply flower, Encore edibles, On the Rocks concentrates and extracts, and (the) Essence and Savvy flower and extracts, spanning an extensive array of options for patients.
Both Trulieve and Verano are active supporters of the Smart and Safe Florida campaign advocating for the passage of the Amendment 3 ballot initiative to legalize adult-use cannabis statewide.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/09/40923340/trump-says-yes-to-legal-cannabis-in-florida-but-hometown-palm-beach-says-no-thanks-to-weed-shops">Trump Says Yes To Legal Cannabis In Florida, But Hometown Palm Beach Says No Thanks To Weed Shops</a>
<h3 class="wp-block-heading">New York's Cannabis Dispensary Tour Amid New Store Openings</h3>
In New York, Democratic Assembly member John Zaccaro and cannabis fin-tech company Dutchie visited three prominent cannabis dispensaries in the Bronx earlier this month. The tour highlighted the role of these businesses in the community alongside ongoing efforts to combat the illicit market.
Florida-based medical cannabis company The Flowery recently announced the opening of its newest store in the neighborhood of Forest Hills, Queens. The grand opening event at a new store at&nbsp;63-54 108th Street in Forest Hills, New York, follows the launch of the company's first New York location in Staten Island. The store features a direct-to-consumer (DTC) delivery program.
<h3 class="wp-block-heading">New Cannabis Stores In Five States</h3>
In the Golden State, cannabis retail brand Solful will open its third dispensary location in Healdsburg on Oct.11. Solful already boasts award-winning dispensaries in San Francisco and Sebastopol,
Located at 465 Healdsburg Ave in Healdsburg, the new store will offer locally sourced cannabis products, featuring 40 cannabis varieties from local farms.
International cannabis and lifestyle brand Cookies held a ribbon-cutting ceremony on Friday, Sept. 20 at its new medical marijuana dispensary in Louisiana in partnership with Capitol Wellness Solutions. Cookies by Capitol Wellness is a 4,800 square feet store and it offers a wide variety of Cookies products and merchandise such as flower, metered-dose inhalers, extracts, edibles, tinctures and creams.
Cannabis dispensary Sweetspot Farms at 139 Pearl St in Essex Junction, Vermont is now open to cannabis customers. The new store has a strong focus on consumer education and service.
High Haven Cannabis held a grand opening event at a retail dispensary in Elgin, Illinois, on Saturday, Sept. 21.
Vertically-integrated cannabis company Ascend Wellness Holdings, Inc. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/AAWH#CSE">AAWH</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/AAWH#OTCQX">AAWH</a>) opened its fifth medical dispensary in Pennsylvania, located in Whitehall. The expansion marks the company's 39th location across its seven-state footprint.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/08/40150356/heres-where-to-buy-legal-weed-new-yorks-cannabis-market-expands-other-states-are-keeping-up">Here&#8217;s Where To Buy Legal Weed: New York&#8217;s Cannabis Market Expands, Other States Are Keeping Up</a></li>
</ul>
Photo: Courtesy of Cova Software on Unsplash

Entrepreneurship

CSE:AAWH

CSE:GTII

GTII

Cannabis Sales Bloom In First North Carolina Weed Store, Marijuana Footprint In Florida Grows As Rec Legalization Looms, And More Store Openings

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed up 1491.67% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/BMMJ">Body and Mind</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BMMJ#OTC">BMMJ</a>) shares closed up 42.26% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/ELLXF">Elixinol Wellness</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ELLXF#OTC">ELLXF</a>) shares closed up 22.73% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/OILFF">Nextleaf Solutions</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OILFF#OTC">OILFF</a>) shares closed up 18.97% at $0.07</li>
<li><a href="https://www.benzinga.com/quote/FUAPF">Global Compliance</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FUAPF#OTC">FUAPF</a>) shares closed up 16.58% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/LMLLF">Pharmadrug</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LMLLF#OTC">LMLLF</a>) shares closed up 11.52% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/BBRRF">Blueberries Medical</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BBRRF#OTC">BBRRF</a>) shares closed up 4.00% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/NWVCF">EnWave</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed up 3.95% at $0.15</li>
<li><a href="https://www.benzinga.com/quote/OGI">OrganiGram Holdings</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OGI#NASDAQ">OGI</a>) shares closed up 3.26% at $1.80</li>
<li><a href="https://www.benzinga.com/quote/CNTMF">Cansortium</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNTMF#OTC">CNTMF</a>) shares closed up 3.05% at $0.17</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/CRBP">Corbus Pharmaceuticals</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) shares closed down 61.70% at $19.51</li>
<li><a href="https://www.benzinga.com/quote/CBDY">Target Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBDY#OTC">CBDY</a>) shares closed down 31.03% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed down 18.03% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/ITHUF">iAnthus Capital Hldgs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ITHUF#OTC">ITHUF</a>) shares closed down 13.85% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CURR">Currenc Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CURR#NASDAQ">CURR</a>) shares closed down 10.27% at $2.95</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed down 10.00% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/VFF">Village Farms Intl</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) shares closed down 9.18% at $0.85</li>
<li><a href="https://www.benzinga.com/quote/CXXIF">C21 Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CXXIF#OTC">CXXIF</a>) shares closed down 7.76% at $0.22</li>
<li><a href="https://www.benzinga.com/quote/UGRO">Urban-gro</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UGRO#NASDAQ">UGRO</a>) shares closed down 5.76% at $1.31</li>
<li><a href="https://www.benzinga.com/quote/BLGVF">Belgravia Hartford Cap</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BLGVF#OTC">BLGVF</a>) shares closed down 5.50% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/GRWG">GrowGeneration</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>) shares closed down 5.12% at $2.04</li>
<li><a href="https://www.benzinga.com/quote/EAST">Eastside Distilling</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EAST#NASDAQ">EAST</a>) shares closed down 4.94% at $0.51</li>
<li><a href="https://www.benzinga.com/quote/SNDL">SNDL</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDL#NASDAQ">SNDL</a>) shares closed down 4.76% at $1.99</li>
<li><a href="https://www.benzinga.com/quote/MRMD">MariMed</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MRMD#OTC">MRMD</a>) shares closed down 4.59% at $0.16</li>
<li><a href="https://www.benzinga.com/quote/CPHRF">Cipher Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CPHRF#OTC">CPHRF</a>) shares closed down 3.53% at $10.67</li>
<li><a href="https://www.benzinga.com/quote/TLRY">Tilray Brands</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed down 3.38% at $1.72</li>
<li><a href="https://www.benzinga.com/quote/YCBD">cbdMD</a> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) shares closed down 3.33% at $0.47</li>
<li><a href="https://www.benzinga.com/quote/XXII">22nd Century Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) shares closed down 3.15% at $0.26</li>
<li><a href="https://www.benzinga.com/quote/TCNNF">Trulieve Cannabis</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>) shares closed down 3.02% at $11.04</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BLGVF

CPHRF

CRBP

SNDL

TLRY

UGRO

Cannabis Stock Movers For September 20, 2024

A Georgia pharmacy has started selling low-THC medical marijuana to registered patients statewide, despite opposition from the <a href="https://www.benzinga.com/topic/drug-enforcement-administration">Drug Enforcement Administration (DEA).</a>
Vic Johnson, who owns the Living Well Pharmacy in Augusta, <a href="https://www.ajc.com/news/health-news/independent-georgia-pharmacy-is-dispensing-medical-marijuana-defying-dea-warning/ZML4KLIPQ5HQDLZ4GIRU27MXLI/">told</a> the Journal-Constitution that selling medical cannabis in pharmacies is "a new frontier."
Why? "I really think pharmacies are an ideal outlet for dispensing medical cannabis because if you come to my pharmacy already, we can talk about what medications you already are taking."
The Georgia Board of Pharmacy started accepting applications from nearly 120 pharmacies to provide medical marijuana products in October, making it the first state in the nation to allow the sale of low-dose cannabis at independent drug stores. The move came four years after the Georgia legislature legalized low-THC medical marijuana in 2019.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/cannabis-conference/"><img loading="lazy" decoding="async" width="970" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20133836/ccc-oct-24-banner__1_-33.gif" alt="" class="wp-image-558952" /></a></figure>
Botanical Sciences LLC and Trulieve Cannabis Corp. (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTCQX">TCNNF</a>), which were the first cannabis businesses to launch medical cannabis sales statewide in 2023, were given the green light to supply pharmacies with products.
Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.
<h3 class="wp-block-heading">DEA Is Against It</h3>
The DEA sent warning letters to pharmacies involved in the state&#8217;s medical marijuana program shortly after, cautioning against dispensing THC. Even though the DEA's move prompted concerns among industry stakeholders about potential obstacles to the expansion of medical marijuana access for patients statewide, the Georgia Access to Medical Cannabis Commission (GMCC) maintained its stance.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/23/12/36246587/dea-vs-georgia-tensions-rise-over-medical-cannabis-access-as-state-regulators-consider-legal-act">DEA vs. Georgia: Tensions Rise Over Medical Cannabis Access As State Regulators Consider Legal Action</a>
"I want patients to know that we are well on our way to fully implement the Hope Act [Harnessing Opportunities by Pursuing Expungement Act]," GMCC chair Sid Johnson said. "We will continue to pursue our mission of ensuring access to medical cannabis for all patients across Georgia."
Johnson's pharmacy was earlier approved by the Georgia Board of Pharmacy to dispense low-THC oil to Richmond County's registered patients. He said his pharmacy got the green light to sell medical cannabis gummies, tinctures, cremes or capsules that contain 5% THC or marijuana compound in late August.
"I think our customers feel more comfortable buying this product through a pharmacy where records are kept, and we know their medical history," Johnson <a href="https://augustabusinessdaily.com/local-pharmacy-creating-a-buzz-with-thc-sales/">told</a> Augusta Business Daily. "The other benefit is that the purchases for these products are kept separate from other prescriptions we fill."
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/23/10/35491477/cannabis-milestone-over-the-counter-medical-marijuana-launches-in-georgia-pharmacies">Cannabis Milestone: Over-The-Counter Medical Marijuana Launches In Georgia Pharmacies</a></li>
</ul>
Photo: Africa Studio/Shutterstock.com

Buying Cannabis At Pharmacy Feels 'More Comfortable,' Says Owner Of Georgia Drugstore Launching Low-THC MMJ Sales

West Virginia should legalize recreational cannabis and join the growing number of states that already took that step. That's according to Huntington Mayor Steve Williams, who is a Democratic candidate for governor of the Mountain State.
Voters should weigh in on the issue via a statewide constitutional amendment, Williams said this week, <a href="https://wvmetronews.com/2024/09/18/williams-adults-should-have-a-choice-about-recreational-marijuana-morrisey-im-not-for-adding-more-drugs-into-our-state/">reported</a> WV MetroNews. He added cannabis reform would have to get the green light from the state's legislature as well, in order to become law.
"West Virginia has an opportunity to join the growing number of states, including Maryland, Ohio, Virginia and Washington, D.C., that have taken bold steps to legalize cannabis, and I believe it's time we give the people a voice on this issue," Williams said. "One avenue to move forward is to put legalization on the ballot and let voters decide."
In addition to having a positive effect on the state's tax revenues that would then be allocated to education, health care and infrastructure projects, cannabis policy change would also create more jobs while boosting businesses and tourism, Williams continued.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/cannabis-conference/"><img loading="lazy" decoding="async" width="970" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19113810/ccc-oct-24-banner__1_-30.gif" alt="" class="wp-image-556612" /></a></figure>
Williams also praised the benefits of a regulated cannabis industry. "By legalizing and regulating cannabis, we can create a safer, controlled environment for consumers and ensure that products are tested and free from harmful substances," he said.
Williams supports cannabis policy change in a state that's facing a grim reality as tit has the highest rate of fatal fentanyl overdoses in the nation. The trend resulted in 80.9 deaths per 100,000 people in 2022, <a href="https://www.cdc.gov/nchs/pressroom/states/westvirginia/wv.htm">according</a> to the Centers for Disease Control and Prevention (CDC).
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/03/37445551/overdose-crisis-worsens-the-rise-of-fentanyl-smoking-leads-to-even-more-deaths-than-shooting-her">Overdose Crisis Worsens: The Rise Of Fentanyl Smoking Leads To Even More Deaths Than Shooting Heroin</a>
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.</li>
</ul>
<h1 class="wp-block-heading">Williams' GOP Opponent Is Against Weed Legalization</h1>
That said, West Virginia Attorney General Patrick Morrisey, who secured the Republican nomination in the state governor race in May, doesn't see the legalization of cannabis as the answer to the substance use disorder crisis statewide.
Williams criticized his stance on cannabis, suggesting Morrisey is under the influence of the pharmaceutical industry.
"My opponent opposes legalization because Big Pharma opposes it," Williams said. "Patrick Morrisey wants to protect a lucrative revenue stream that has made billions for Big Pharma while wreaking havoc and bringing misery and death to West Virginia."
Interestingly, Morrisey's partisan colleague, state Senate President&nbsp;Craig Blair (R) is of a different stance, as he previously called <a href="https://www.benzinga.com/markets/cannabis/24/01/36563305/gop-state-senate-pres-pushes-for-legalized-marijuana-to-combat-west-virginias-fentanyl-crisis">for marijuana legalization</a> as a possible means to <a href="https://www.benzinga.com/markets/cannabis/24/01/36694868/another-push-to-legalize-recreational-cannabis-in-west-virginia-amid-fentanyl-crisis">address the state&#8217;s fentanyl crisis.</a>
&#8220;My gut tells me it might not happen this year," Blair&nbsp;<a href="https://wvpublic.org/firefighter-funding-cybersecurity-cannabis-discussed-at-legislative-lookahead/">said</a> at an annual event sponsored by the West Virginia Press Association. "But you're going to see it sooner than later because that is a way to combat the issue."
Either way, previous attempts to legalize recreational cannabis statewide have all failed. Del.&nbsp;Evan Hansen's (D)&nbsp;<a href="https://www.wvlegislature.gov/bill_status/bills_text.cfm?billdoc=hb4873%20intr.htm&amp;yr=2024&amp;sesstype=RS&amp;i=4873">House Bill 4873</a>, introduced in January, which&nbsp;would have legalized marijuana for adults over 21, allowed cannabis sales by licensed operators and provided labeling regulations, <a href="https://www.benzinga.com/markets/cannabis/24/01/36694868/another-push-to-legalize-recreational-cannabis-in-west-virginia-amid-fentanyl-crisis">died in a committee.</a>
Multistate medical marijuana operators that would benefit from adult-use legalization in West Virginia include Trulieve Cannabis Corp (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>) and Verano Holdings Corp. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/VRNOF#OTC">VRNOF</a>), among others.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/04/38416745/three-pathways-to-federal-cannabis-legalization-that-investors-are-watching-closely">Three Pathways To Federal Cannabis Legalization That Investors Are Watching Closely</a></li>
</ul>
Photos: Shutterstock

Candidates For West Virginia Governor Are Split Over Weed Legalization: Here's What Voters Should Know

A six-figure campaign event at a luxury Georgia resort aimed at <a href="https://www.benzinga.com/topic/florida-cannabis" target="_blank" rel="noopener">opposing Florida's cannabis</a> and abortion amendments ended up losing money rather than generating a profit.
What Happened: The Ron <a href="https://www.benzinga.com/markets/cannabis/24/06/39279951/desantis-new-freedom-fund-has-2-stated-goals-defeat-cannabis-legalization-and-abortion-amendment">DeSantis-affiliated Florida Freedom Fund</a>, formed in late-May with the stated goal of defeating cannabis legalization and restoring abortion access, "blew through nearly $116,000 between Aug. 31 and Sept. 6, even though it raised just over $41,000 in the same time," <a href="https://floridapolitics.com/archives/696216-ron-desantis-tied-committee-spends-big-on-georgia-ritz-carlton-retreat-as-it-fights-pot-abortion-initiatives-in-florida/">reported</a> Florida Politics. Most of that, about $115,000, went to cover costs at the Ritz-Carlton in Georgia. This spending constitutes over a third of the campaign's total expenditures since it launched. 
The cannabis legalization initiative, known as Amendment 3, is set to go before Florida voters in <a href="https://www.benzinga.com/markets/cannabis/24/04/38034138/florida-supreme-court-approves-cannabis-legalization-proposal-for-november-election-in-blow-to-d" target="_blank" rel="noopener">the upcoming November elections</a>.
Despite the lavish spending, the committee raised just over $41,000 during the same period, marking the second time its expenditures outpaced contributions. Both the Florida Freedom Fund and Keep Florida Clean, another anti-amendment group linked to DeSantis, have struggled with more spending than fundraising since September. Keep Florida Clean spent more than $286,000 in the same period but raised just $1,600.
<ul>
<li>Get Benzinga&#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you&#8217;re serious about the business, you can&#8217;t afford to miss out.</li>
</ul>
<h2 class="wp-block-heading">Pro-Cannabis Committee Is Flush: Millions Keep Coming In</h2>
Meanwhile, Amendment 3, which is now the best-funded cannabis legalization amendment in American history, has no shortage of cash on hand. Led by the <a href="https://drupal-cloudfront.benzinga.com/topic/smart-safe-florida">Smart &amp; Safe Florida</a> committee, the amendment received $90.44 million through Aug. 30, <a href="https://news.ballotpedia.org/2024/09/18/florida-amendment-3-exceeds-previous-records-for-marijuana-legalization-campaign-contributions/">according to Ballotpedia</a>.
As of Sept. 6, Florida's largest medical marijuana company, Trulieve Cannabis Corp (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>), had contributed $87.77 million in cash and in-kind contributions to the Smart &amp; Safe committee since 2022, reported News Service of Florida, citing a state database.
DeSantis <a href="https://www.benzinga.com/markets/cannabis/24/09/40926862/desantis-targets-one-big-weed-company-funding-floridas-legalization-campaign-cites-corporate-int">lashed out</a> recently at Trulieve, calling the company a corporate monopoly that seeks to corner the cannabis market.
Read More: <a href="https://www.benzinga.com/markets/cannabis/24/09/40926862/desantis-targets-one-big-weed-company-funding-floridas-legalization-campaign-cites-corporate-int">DeSantis Targets &#8216;One Big Weed Company&#8217; Funding Florida&#8217;s Legalization Campaign, Citing &#8216;Corporate Interests&#8217;</a>
<h2 class="wp-block-heading">Anti-Cannabis Committees Having Trouble Keeping Up</h2>
Both the Florida Freedom Fund and Keep Florida Clean committees are chaired by James Uthmeier, DeSantis' chief of staff and former campaign manager when the governor ran for president. As of Sept. 6, the Florida Freedom Fund had a little more than $3.4 million remaining in cash. Keep Florida Clean had just over $3.9 million, noted Florida Politics.
While fundraising has been lackluster, the Florida Freedom Fund received several notable donations, including $25,000 from Next Generation Energy Corporation (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NGMC#OTC">NGMC</a>) and $10,000 from a Pompano Beach retiree. The outlet noted that the committee continues to rely heavily on a mid-August  $12 million donation from Citadel CEO Ken Griffin.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/09/40923340/trump-says-yes-to-legal-cannabis-in-florida-but-hometown-palm-beach-says-no-thanks-to-weed-shops">Trump Says Yes To Legal Cannabis In Florida, But Hometown Palm Beach Says No Thanks To Weed Shops</a></li>
</ul>
Photo by Hvoenok-and-GOR-Photos

NGMC

DeSantis-Backed Anti-Cannabis PACs 'Blew Through' $116K At Fundraiser, While Pro-Pot Group Holds $90M War Chest

As Florida prepares for a critical vote on recreational cannabis legalization this November, Governor Ron DeSantis is intensifying his campaign against Amendment 3, this time challenging cannabis giant Trulieve (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>) (CSE:<a class="ticker" href="https://www.benzinga.com/stock/TRUL#CSE">TRUL</a>). In an effort to counter what the <a href="https://www.benzinga.com/markets/cannabis/24/08/40418144/florida-cannabis-legalization-one-poll-shows-weed-going-legal-in-november-ballot-another-thumbs-">polls show</a> as a majority of support for recreational cannabis, the governor is presenting brand new creative arguments.
On Tuesday, the Anti-Amendment 3 X account &#8216;Vote No on 3&#8217; shared a video wherein DeSantis appears to target &#8220;one big weed company,&#8221; as cannabis legalization&#8217;s <a href="https://www.benzinga.com/markets/cannabis/24/05/38730627/medical-marijuana-giant-trulieve-backer-of-floridas-recreational-cannabis-ballot-narrows-loss-re">main backer</a>. He calls Trulieve a corporate monopoly that seeks to profit from a captive market and accuses the medical marijuana company of being led by &#8220;corporate interests.&#8221;
<h2 class="wp-block-heading">Fighting &#8216;Corporate Cannabis&#8216;</h2>
Vote No on 3 posted the DeSantis video. "One big weed company that spent 75 to 80 million dollars… writes in there that you have a right to possess and use marijuana, but only if you buy it from them; you can't grow it in your backyard."
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">&#x1f440; <a href="https://twitter.com/GovRonDeSantis?ref_src=twsrc%5Etfw">@GovRonDeSantis</a> laid it out: Amendment 3 is not pro-freedom, it&#39;s pro-monopoly. Instead of giving you the freedom to grow in your backyard, Amendment 3 would allow unchecked public use. <a href="https://t.co/NKhJpBcq9C">pic.twitter.com/NKhJpBcq9C</a>
&mdash; Vote No on 3 (@VoteNo_On3) <a href="https://twitter.com/VoteNo_On3/status/1836082394782110002?ref_src=twsrc%5Etfw">September 17, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
This statement is surprising for two reasons: it misrepresents cannabis regulations in other legal states, where <a href="https://www.benzinga.com/markets/cannabis/24/04/37988501/59-of-americans-support-right-to-grow-legal-cannabis-at-home-new-survey-finds">home cultivation</a> is often permitted, while portraying DeSantis as supportive of home cultivatation, a stance that <a href="https://www.benzinga.com/markets/cannabis/24/05/38649648/ron-desantis-plan-to-scuttle-floridas-cannabis-legalization-initiative-with-his-vast-fundraising">contradicts his previous positions</a>.
While DeSantis opposes the legalization of recreational cannabis, supporting legislation that allows residents to grow their own plants could address some concerns about access and the illegal market.
Instead, De Santis has been <a href="https://www.benzinga.com/markets/cannabis/24/07/39760907/ron-desantis-floridas-gop-and-hemp-industry-pile-on-to-defeat-marijuana-legalization">financially backed </a>by another type of manufacturer: the hemp derivatives groups. Some of the companies in this sector profit from an unregulated environment that enables them to avoid the tax burden and manufacturing controls imposed on cannabis companies.
DeSantis vetoed a bill that would have banned hemp-based products this past July.
Benzinga reached out to Trulieve for comments on DeSantis&#8217; remarks. 
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/09/40820699/trump-stuck-in-southern-border-and-immigration-loop-during-harris-debate-theyre-destroying-our-c">Trump Stuck In Southern Border And Immigration Loop During Harris Debate: &#8216;They&#8217;re Destroying Our Country&#8217;</a>
<h3 class="wp-block-heading">Running Against Trulieve</h3>
DeSantis&#8217; remarks reflect his complicated relationship with the cannabis industry.
Trulieve, which has invested heavily in the Smart &amp; Safe campaign for Amendment 3, is a major player in the Florida medical cannabis market. However, it&#8217;s far from being a monopoly, as the X post reads and the governor implies.
According to the most <a href="https://knowthefactsmmj.com/wp-content/uploads/ommu_updates/2024/091324-OMMU-Update.pdf">recent data</a> from the Office of Medical Marijuana Use (OMMU), Trulieve operates 22% of the state's dispensaries, accounting for 30% of total medical marijuana sales and 10% of low-THC cannabis products. It&#8217;s clear that the company is not the only cannabis business in Florida.
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.</li>
</ul>
<h3 class="wp-block-heading">DeSantis&#8217; Closing Arguments</h3>
DeSantis also <a href="https://x.com/VoteNo_On3/status/1836135532931207310">expressed concerns</a> about marijuana use in public spaces, which is a typical regulatory concern with cannabis (similar to alcohol and tobacco).
He stated, "I don't think that there's any place in the country that has successfully limited the use."
Instead of dismissing the issue outright, one might consider that what was possible for alcohol and tobacco is also possible for cannabis. <a href="https://www.benzinga.com/markets/cannabis/22/07/28121844/tft-what-cannabis-lounges-could-mean-for-the-future-of-weed-consumption">Consumption lounges</a>, for instance, are a great solution for crowded areas.
If you are curious about Amendment 3, you can find the text of the initiative <a href="https://initiativepetitions.elections.myflorida.com/InitiativeForms/Fulltext/Fulltext_2205_EN.pdf">here</a>.
<ul>
<li>Read Next: <a href="https://www.benzinga.com/markets/cannabis/24/09/40923340/trump-says-yes-to-legal-cannabis-in-florida-but-hometown-palm-beach-says-no-thanks-to-weed-shops">Trump Says Yes To Legal Cannabis In Florida, But Hometown Palm Beach Says No Thanks To Weed Shops</a></li>
</ul>
Cover: Photo: Benzinga&nbsp;edit of image by&nbsp;<a href="https://unsplash.com/fr/@mrbrodeur?utm_source=unsplash&amp;utm_medium=referral&amp;utm_content=creditCopyText" target="_blank" rel="noreferrer noopener">Matthew Brodeur</a>&nbsp;on&nbsp;<a href="https://unsplash.com/photos/qcCPIhhdgTw?utm_source=unsplash&amp;utm_medium=referral&amp;utm_content=creditCopyText" target="_blank" rel="noreferrer noopener">Unsplash</a>&nbsp;and Wikimedia Commons<a href="https://benzinga.com/apis" target="_blank" rel="noreferrer noopener"></a>

DeSantis Targets 'One Big Weed Company' Funding Florida's Legalization Campaign, Citing 'Corporate Interests'

In a bipartisan effort, two Florida state senators have come together to promote the Florida cannabis legalization initiative, known as <a href="https://drupal-cloudfront.benzinga.com/topic/amendment-3">Amendment 3</a> that will appear on the ballot in the <a href="https://www.benzinga.com/markets/cannabis/24/03/37992749/florida-supreme-court-shelves-cannabis-ballot-proposal-with-no-explanation-or-provisions-as-apri" target="_blank" rel="noreferrer noopener">November 2024 election</a>. Republican Sen. <a href="https://www.benzinga.com/markets/cannabis/24/08/40441169/florida-senator-proposes-outdoor-smoking-ban-if-weed-is-legalized-jacksonville-sheriff-dead-set-">Joe Gruters</a> and Democratic Sen. Shevrin Jones are featured in a new ad sponsored by the <a href="https://www.benzinga.com/markets/cannabis/24/04/38313915/cannabis-in-florida-the-bellamy-brothers-tell-trulieve-ceo-we-rolled-a-fat-one-when-legalization" target="_blank" rel="noreferrer noopener">Smart &amp; Safe Florida</a> campaign.
Gruters, a former chair of the Florida Republican Party, and Jones, a prominent Democratic senator, acknowledge that they "don't agree on much—hardly anything" and would each be voting for their respective party's presidential nominee, but legalizing marijuana is an issue they can both get behind.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Florida State Senator and Miami-Dade DEC Chairman <a href="https://twitter.com/ShevrinJones?ref_src=twsrc%5Etfw">@ShevrinJones</a> and State Senator and Former Republican Party of Florida Chair <a href="https://twitter.com/JoeGruters?ref_src=twsrc%5Etfw">@JoeGruters</a> may not agree on much, but they DO agree that safe, regulated marijuana is the right call for Florida. <a href="https://twitter.com/hashtag/YesOn3?src=hash&amp;ref_src=twsrc%5Etfw">#YesOn3</a> <a href="https://t.co/vRWJXzZhfu">pic.twitter.com/vRWJXzZhfu</a>
&mdash; Smart &amp; Safe Florida (@SmartandSafeFl) <a href="https://twitter.com/SmartandSafeFl/status/1833837189274206324?ref_src=twsrc%5Etfw">September 11, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Read Also:<a href="https://www.benzinga.com/markets/cannabis/24/09/40798916/desantis-vs-trump-over-florida-cannabis-legalization-guess-whos-winning"> DeSantis Vs. Trump Over Florida Cannabis Legalization: Guess Who&#8217;s Winning</a>
Gruters <a href="https://www.benzinga.com/markets/cannabis/24/07/40085870/ron-desantis-and-gop-stalwart-feud-over-cannabis-legalization-trump-floridas-top-cops-also-weigh" target="_blank" rel="noreferrer noopener">came out in favor</a>&nbsp;of cannabis legalization over the summer and Jones stressed the social justice aspects of the measure. He says legalizing cannabis would bring justice to marginalized communities that have been, still are, disproportionately affected by marijuana prohibition laws.
The amendment, if passed, would also channel tax revenue from legal marijuana sales into critical areas such as public education and law enforcement, a point both senators made. 
Meanwhile, Gov. <a href="https://www.benzinga.com/topic/ron-desantis">Ron DeSantis</a>, who <a href="https://www.benzinga.com/markets/cannabis/24/07/39827912/ron-desantis-blasts-floridas-cannabis-legalization-ballot-at-rnc-it-would-allow-80-joints-a-day-" target="_blank" rel="noreferrer noopener">vehemently opposes</a> the legalization measure <a href="https://www.benzinga.com/markets/cannabis/24/09/40798916/desantis-vs-trump-over-florida-cannabis-legalization-guess-whos-winning">said recently</a> that the cannabis legalization initiative in Florida is the result of &#8220;one weed company,&#8221; the medical marijuana company Trulieve Cannabis Corp (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>), which he called a &#8220;de facto monopoly" and a "weed cartel."
Get Benzinga&#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you&#8217;re serious about the business, you can&#8217;t afford to miss out.
<h2 class="wp-block-heading">Money To Be Made</h2>
At a roundtable in mid-June week in Tampa, Safe &amp; Smart<a href="https://www.benzinga.com/markets/cannabis/24/06/39346531/desantis-cant-get-past-the-odor-of-weed-to-smell-the-flowers-specifically-430m-annually-in-canna"> quoted economists</a> who estimate that legalizing marijuana could generate between $195 million and $431 million annually in sales tax revenue, providing a significant boost to the state's economy. 
Florida isn't alone in this potential windfall—other <a href="https://www.benzinga.com/markets/cannabis/24/05/38712820/legal-cannabis-states-raked-in-20b-since-2014-peaking-at-4b-in-2023-new-report-shows">states with legal marijuana </a>are raking in around $20 billion in tax revenue, according to legalization advocates. However, this appears insufficient to sway DeSantis.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/08/40383353/ron-desantis-slams-trulieves-alleged-canadian-ties-in-his-battle-against-cannabis-legalization">Ron DeSantis Slams Trulieve&#8217;s Alleged &#8216;Canadian&#8217; Ties In His Battle Against Cannabis Legalization</a></li>
</ul>
Image generated using artificial intelligence via Midjourney.

GOP And Democratic State Senators Back Florida's Cannabis Legalization Initiative In New Ad As Ballot Vote Looms

<a href="https://www.benzinga.com/topic/donald-trump">Donald Trump</a> and Florida Governor <a href="https://www.benzinga.com/topic/ron-desantis">Ron DeSantis </a>continue to square off over cannabis legalization, with the former supporting and the latter opposing.
"As a Floridian, I will be voting YES on Amendment 3 this November," Trump <a href="https://www.benzinga.com/markets/cannabis/24/09/40774795/trump-says-hell-reschedule-cannabis-if-elected-backs-marijuana-banking-reform-and-floridas-amend">wrote</a> Sunday in a Truth Social post. "As President, we will continue to focus on research to unlock medical uses of marijuana to a schedule 3 drug, and work with Congress to pass common sense laws."
Shortly before Trump's remarks hit the wires, DeSantis <a href="https://www.youtube.com/watch?v=lDgT9g_TUlU">told</a> a gathering at City Church Tallahassee that the cannabis legalization initiative, known as Amendment 3, was "coming because of one weed company, Trulieve who basically has a de facto monopoly" or a "weed cartel." He proceeded to accuse the CEO of Florida medical marijuana giant, Trulieve Cannabis Corp (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>) of having personally written the ballot amendment.
But when it comes to Trump's newly-found support of legal cannabis, both in Florida and on a national level, DeSantis is still not commenting or casting aspersions.
<h2 class="wp-block-heading">Casey DeSantis Takes Up The Anti-Weed Battle</h2>
However, Casey DeSantis isn&#8217;t shy about sharing her thoughts on the matter, even if she&#8217;s echoing her husband&#8217;s views — and that&#8217;s fine.
&#8220;Amendment 3 creates a permanent, constitutional right to possess over 100 joints at a time and SMOKE ANYWHERE in Florida—even public places where it could more easily fall into the hands of children,&#8221; she posted on X.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/09/40782415/top-dem-congressman-calls-trumps-cannabis-support-a-powerful-signal-to-gop-when-even-donald-trum">Top Dem Congressman Calls Trump&#8217;s Cannabis Support A &#8216;Powerful Signal&#8217; To GOP: &#8216;When Even Donald Trump Can Get On Board&#8230;&#8217;</a>
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Amendment 3 creates a permanent, constitutional right to possess over 100 joints at a time and SMOKE ANYWHERE in Florida—even public places where it could more easily fall into the hands of children. What's more, it creates a monopoly &amp; blanket legal immunity for big weed… <a href="https://t.co/Fv5eXDW6t2">https://t.co/Fv5eXDW6t2</a>
&mdash; Casey DeSantis (@CaseyDeSantis) <a href="https://twitter.com/CaseyDeSantis/status/1833198813970133201?ref_src=twsrc%5Etfw">September 9, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The DeSantis couple are not the only Republicans fuming over Trump&#8217;s endorsement of legal weed in the Sunshine state. 
Stuart Stevens, chief strategist for Mitt Romney&#8216;s 2012 presidential campaign, told <a href="https://www.newsweek.com/topic/msnbc">MSNBC</a> that the former president was essentially a hypocrite who&#8217;d say anything to get ahead. &#8220;Donald Trump, he&#8217;s on both sides of so many of these issues. I mean, within an hour he reversed himself on what position he was going to take on the abortion referendum in Florida. It&#8217;s because there&#8217;s nothing there except this desire to be president, this desire to be in control … so he&#8217;ll say anything.&#8221;
Several other GOP stalwarts joined Stevens in his criticism of the former president, <a href="https://www.newsweek.com/donald-trumps-marijuana-stance-sparks-anger-some-florida-republicans-1951273">reported</a> Newsweek.
Actually, the Republicans&#8217; comments were not unlike those made by Vice President Kamala Harris&#8216; presidential campaign team, which referred to Trump&#8217;s cannabis announcement as &#8220;blatant pandering.&#8221;
Read more on that:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/09/40785015/harris-campaign-accuses-trump-of-blatant-pandering-and-lying-about-his-cannabis-support-announce">Harris Campaign Accuses Trump Of &#8216;Blatant Pandering&#8217; And Lying About His Cannabis Support Announcemen</a>t</li>
</ul>
Photo: Benzinga edit with images by&nbsp;<a href="https://en.wikipedia.org/wiki/en:Shealah_Craighead" target="_blank" rel="noreferrer noopener">Shaleah Craighead</a>&nbsp;and&nbsp;<a href="https://www.flickr.com/people/22007612@N05" target="_blank" rel="noreferrer noopener">Gage Skidmore</a>&nbsp;on Wikimedia Commons and Kindel Media on Pexels

DeSantis Vs. Trump Over Florida Cannabis Legalization: Guess Who's Winning

Former President Donald Trump announced on Sunday night that, if re-elected, he would reschedule cannabis and support banking reforms for the marijuana industry. He also confirmed his support for Florida's Amendment 3, which would legalize recreational cannabis in the state. Trump's <a href="https://www.benzinga.com/markets/cannabis/24/09/40774795/trump-says-hell-reschedule-cannabis-if-elected-backs-marijuana-banking-reform-and-floridas-amend">comments</a> sparked a reaction in the cannabis stock market on Monday.
Get Benzinga's exclusive analysis and top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.
<h3 class="wp-block-heading">Stocks Reaction</h3>
<ul>
<li>Trulieve Cannabis (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>): The price at market close was $10.99 with a change of +$1.28 (+13.18%). Trading volume reached 707,392, with a market cap of $2.06 billion.</li>
<li>Green Thumb Industries (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTC">GTBIF</a>): The price at market close was $10.66 with a change of +$1.02 (+10.58%). Trading volume hit 473,092, with a market cap of $2.52 billion.</li>
<li>Curaleaf Holdings (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>): The price at market close was $3.10 with a change of +$0.26 (+9.15%). Trading volume reached 639,920, and the market cap stood at $2.09 billion.</li>
<li>Canopy Growth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>): The price at market close was $4.86 with a change of +$0.38 (+8.54%). Trading volume was 6,041,892, with a market cap of $412 million.</li>
<li>Sundial Growers (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDL#NASDAQ">SNDL</a>): The price at market close was $2.14 with a change of +$0.16 (+8.08%). Trading volume hit 1,946,306, and the market cap was $530 million.</li>
<li>Aurora Cannabis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>): The price at market close was $5.80 with a change of +$0.39 (+7.25%). Trading volume was 1,136,294, with a market cap of $317 million.</li>
<li>Cronos Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRON#NASDAQ">CRON</a>): The price at market close was $2.21 with a change of +$0.07 (+3.27%). Trading volume reached 1,448,055, with a market cap of $847 million.</li>
<li>HEXO Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HEXO#NASDAQ">HEXO</a>): The price at market close was $1.35 with a change of +$0.05 (+3.85%). Trading volume was 1,215,840, with a market cap of $401 million.</li>
<li>AdvisorShares Pure US Cannabis ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSOS#NYSE">MSOS</a>): The price at market close was $7.16 with a change of +$0.75 (+11.70%). Trading volume hit 13,998,304.</li>
<li>Innovative Industrial Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IIPR#NYSE">IIPR</a>): The price at market close was $122.69 with a change of +$2.02 (+1.67%). Trading volume was 90,181, with a market cap of $3.42 billion.</li>
<li>GrowGeneration (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>): The price at market close was $1.92 with a change of +$0.05 (+2.96%). Trading volume hit 454,306, and the market cap was $110 million.</li>
<li>Corbus Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>): The price at market close was $52.48 with a change of +$2.43 (+4.87%). Trading volume was 153,424, with a market cap of $630 million.</li>
<li>AdvisorShares Pure Cannabis ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YOLO#NYSE">YOLO</a>): The price at market close was $3.35 with a change of +$0.21 (+6.69%). Trading volume reached 37,519.</li>
<li>Scotts Miracle-Gro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>): The price at market close was $67.62 with a change of -$0.20 (-0.29%). Trading volume reached 323,540, with a market cap of $3.85 billion.</li>
<li>Village Farms International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>): The price at market close was $1.01 with a change of +$0.01 (+1.02%). Trading volume hit 459,136, and the market cap was $113 million.</li>
<li>Trees (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CANN#OTC">CANN</a>): The price at market close was $0.042 with a change of -$0.012 (-22.22%). Trading volume was 118,407.</li>
<li>Medical Marijuana (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MJNA#OTC">MJNA</a>): The price at market close was $0.001 with no change. Trading volume hit 9,393,761, with a market cap of $5.68 million.</li>
<li>OrganiGram Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OGI#NASDAQ">OGI</a>): The price at market close was $1.83 with a change of +$0.08 (+4.29%). Trading volume was 348,054, with a market cap of $186 million.</li>
<li>High Tide (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HITI#NASDAQ">HITI</a>): The price at market close was $2.12 with a change of +$0.16 (+8.16%). Trading volume hit 648,008, with a market cap of $162 million.</li>
<li>Planet 13 Holdings (OTC:<a class="ticker" href="https://www.benzinga.com/stock/PLNHF#OTC">PLNHF</a>): The price at market close was $0.96 with no significant change. Trading volume was 275,004.</li>
<li>Cresco Labs (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>): The price at market close was $1.74 with a change of +$0.13 (+7.74%). Trading volume hit 438,517, with a market cap of $565 million.</li>
</ul>
<h3 class="wp-block-heading">Highs And Lows In 2024&nbsp;</h3>
The cannabis market has experienced several significant stock movements in recent months. On April 30, 2024, stocks soared after the DEA announced plans to reschedule cannabis to Schedule III, with Canopy Growth <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38536953/cannabis-stocks-react-to-dea-rescheduling-canopy-aurora-surge-tilray-wm-tech-hold-s">jumping</a> by 78.8% and Aurora Cannabis rising 46%. 
However, two weeks ago, following the DEA's decision to delay its final ruling, the sector saw a <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/08/40580306/cannabis-stocks-plummet-by-up-to-16-on-dea-rescheduling-delay-could-this-be-the-buy">sharp decline</a>, with Curaleaf falling 15.68% and Green Thumb Industries dropping 10.15%. In contrast, Monday's gains following Trump's support for Amendment 3 were more modest, with a mean growth of 4.31%, suggesting a recovery but not on the same scale as the April surge.
Read Next: <a href="https://www.benzinga.com/markets/cannabis/24/09/40776937/trump-joins-millions-of-americans-who-support-rescheduling-cannabis-weed-industry-responds-to-fo">Trump &#8216;Joins Millions Of Americans&#8217; Who Support Rescheduling Cannabis: Weed Industry Responds To Former Pres&#8217; News</a>

ETFs

CANN

CRON

HEXO

HITI

IIPR

MJNA

MSOS

YOLO

Cannabis Stocks React To Trump's Marijuana Comments: See Which Ones Posted Solid Gains

<h3 class="wp-block-heading">First Weed Shop In North Carolina To Open This Weekend</h3>
The first legal recreational cannabis store in North Carolina is slated to open its doors to customers on Saturday, Sept. 7 at 91 Bingo Loop Road in Cherokee, Swain County, <a href="https://www.citizen-times.com/story/news/local/2024/09/03/north-carolinas-1st-recreational-marijuana-dispensary-set-to-open/75010685007/">reported</a> The Asheville Citizen-Times.
Great Smoky Cannabis Co., an Eastern Band of Cherokee Indians (ECBI) medical marijuana <a href="https://www.benzinga.com/markets/cannabis/24/08/40134964/north-carolinas-first-and-only-recreational-marijuana-shop-opening-soon-thanks-to-eastern-band-o">announced this summer</a> that recreational cannabis was available to adult members of the ECBI and other federally recognized Native American tribes. Now the store opening celebration is about to take place.
 ECBI&#8217;s members said yes to <a href="https://www.benzinga.com/markets/cannabis/23/09/34358061/cherokee-tribe-votes-to-legalize-marijuana-in-north-carolina-despite-gop-congressmans-threats">recreational cannabis on&nbsp;a Sept. 7 referendum in 2023.</a>
<h3 class="wp-block-heading">D.C. MMJ Dispensaries Are At Risk Of Shutting Down, Here's Why</h3>
In Washington D.C. owners of licensed medical cannabis dispensaries say their businesses are at stake as they are affected by the so-called I-71 weed shops as well as the relatively nascent, but burgeoning Maryland cannabis market, reported Axios.
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.</li>
</ul>
That said, the District Is now expected to act on &#8220;gray area&#8221; I-71 shops. Earlier this year, the D.C. Council approved an emergency measure to give city officials the authority to impose penalties on unlicensed marijuana gifting shops not operating under <a href="https://www.benzinga.com/markets/cannabis/24/01/36597430/new-emergency-law-empowers-authorities-to-crack-down-on-cannabis-gifting-shops-in-d-c">the city&#8217;s medical cannabis program.</a> Since then, &nbsp;some have decided to go legit. The Alcoholic Beverage and Cannabis Administration (ABCA) published a list of businesses shortly, looking to transition from D.C.&#8217;s I-71 gifting market to legal medical dispensaries. Out of 76 submitted applications, a total of 26 D.C. unlicensed retailers have been awarded placards, including 12 social equity <a href="https://www.benzinga.com/markets/cannabis/24/02/37220237/dcs-weed-gifting-goes-legit-nebraskans-want-medical-marijuana-legalized-and-more-cannabis-regs">applicants and 14 standard applicants.</a>
Five legal dispensaries went out of business in the past two years, according to Grace Hyde, a director at District Cannabis and co-chair of the Regulated Cannabis Association of DC. One of the reasons are higher prices of products sold in licensed shops, as the product is regulated and sourced from D.C. cultivators.
Hyde urged Mayor Muriel Bowser to tackle the issue of the I-71 shops. &#8220;I would say the industry has — without enforcement — 60 days before we start to collapse,&#8221; she said. &#8220;Our business has not broken even in any single month in 2024.&#8221;
Read Next: <a href="https://www.benzinga.com/markets/cannabis/24/06/39297599/dc-residents-fight-against-cannabis-dispensaries-near-schools-is-there-a-real-danger-for-childre">DC Residents Fight Against Cannabis Dispensaries Near Schools: Is There A Real Danger For Children?</a>
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/cannabis-conference/"><img loading="lazy" decoding="async" width="970" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/06111232/ccc-oct-24-banner__1_-12.gif" alt="" class="wp-image-534890" /></a></figure>
<h3 class="wp-block-heading">Florida Medical Marijuana Giant Ramps Up National Retail Footprint And Other Stores That Launched Cannabis Sales</h3>
Meanwhile, Trulieve Cannabis Corp. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/TRUL#CSE">TRUL</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTCQX">TCNNF</a>) has been ramping up its presence nationwide.
In Florida, the medical cannabis giant launched sales at a new medical cannabis dispensary in Orlando. Located at 6655 S Semoran Blvd, the store started serving patients in late August.
On Friday, the Tallahassee-based company held ribbon-cutting celebrations at three medical cannabis dispensaries including stores in Miramar Beach, Niceville and Tampa, while the Cocoa shop is slated to open on Saturday, Sept. 7.
The same day, Trulieve will launch sales at a new medical cannabis dispensary in Clearwater as well.
The company also relocated its dispensary in Tucson, Arizona. The new Menlo Park location at 1010 S Freeway #130 will host a grand opening celebration starting on Friday, Sept. 13.
Texas Original medical cannabis provider wrapped up last month by announcing the opening of a pickup location in the Katy area. Located at 810 S. Highway 6 #101, the Katy site offers Texas Original's full suite of medical cannabis products to qualifying patients registered under the state's Compassionate Use Program (CUP).
Canadian cannabis retail giant High Tide Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HITI#NASDAQ">HITI</a>) (TSXV:<a class="ticker" href="https://www.benzinga.com/stock/HITI#TSXV">HITI</a>) (FSE: 2LYA) announced on Thursday that its Canna Cabana retail cannabis store located at 389 Main Street, Lucan, Ontario will begin selling recreational cannabis products and consumption accessories for adult use on Friday, Sept. 6. This opening will mark the company&#8217;s 183rd Canna Cabana branded retail cannabis location in Canada, the 69th in the province. 
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/08/40528453/heres-where-to-buy-legal-weed-khalifa-kushs-store-in-las-vegas-west-hollywoods-lgbtq-owned-canna">Here&#8217;s Where To Buy Legal Weed: Khalifa Kush&#8217;s Store In Las Vegas, West Hollywood&#8217;s LGBTQ+ Owned Cannabis Dispensary And More</a></li>
</ul>

TSXV:HITI

First Weed Shop In North Carolina, Why Are D.C. Medical Marijuana Shops Closing Down? More New Places To Buy Legal Cannabis

Nearly a month has passed since Ohio <a href="https://www.benzinga.com/markets/cannabis/24/08/40207399/cannabis-stocks-surge-with-ohios-recreational-sales-kickoff-and-strong-earnings-reports">began selling adult-use cannabis</a> and dispensaries in the Columbus area are reporting continued strong demand. Locals Cannabis and Trulieve Cannabis Corp. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>), both with locations in the city, have observed sustained interest with no indication of a decrease in customers.
<h3 class="wp-block-heading">Legal Weed Buyers Flock To Ohio Dispensaries</h3>
Mandy Morton, owner of Locals Cannabis, noted a significant uptick in patronage. &#8220;We've had at least six times the amount of people that we had before when we were just medical,&#8221; Morton <a href="https://www.wowktv.com/ohio-3/ohio-recreational-marijuana-sales-show-no-signs-of-slowing-down/">told</a> WOWK-TV. &#8220;So the non-medical crowd has definitely come in in full force.&#8221;
Similarly, the <a href="http://benzinga.com/cannabis">cannabis</a> multi-state operator (MSO) Trulieve has experienced a steady flow of patrons. Nick Rassler, director of state operations, highlighted the consistency in customer visits. &#8220;We're still seeing roughly the same volume of people each week that we saw the first launch week,&#8221; said Rassler. &#8220;I think that that'll continue to grow.&#8221;
<ul>
<li>Get Benzinga&#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe">here</a>. If you&#8217;re serious about the business, you can&#8217;t afford to miss out.</li>
</ul>
Both companies report that customers are <a href="https://www.benzinga.com/markets/cannabis/24/08/40492614/smoke-much-weed-ohio-38-5m-in-first-two-weeks-of-adult-use-sales-including-medical-marijuana">becoming more savvy about the purchasing process</a>. &#8220;The first couple weeks we had a longer consultation process with new customers talking them through what to expect in dispensary sales and what products we have available,&#8221; Morton added.
<h3 class="wp-block-heading">Cannabis MSOs Expanding Footprint In Ohio</h3>
In addition Florida-based Trulieve, several other MSOs are capitalizing on Ohio&#8217;s burgeoning <a href="http://benzinga.com/topic/ohio-cannabis">marijuana market</a>. These include Verano Holdings Corp. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/VRNOF#OTC">VRNOF</a>), the Cannabist Company Holdings Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBSTF#OTC">CBSTF</a>), Curaleaf Holdings Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>), Rise Dispensaries, Acreage Holdings Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ACRHF#OTC">ACRHF</a>), Green Thumb Industries Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTC">GTBIF</a>) and Cresco Labs Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>).
Financially, the sector has shown impressive figures. WOWK-TV notes that according to the Ohio Division of Cannabis Control, adult-use marijuana sales have already topped $44 million as of Saturday.&nbsp;
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/08/40527752/ohios-sales-surge-might-cast-trouble-for-michigans-cannabis-market-heres-why">Ohio's Cannabis Sales Surge Might Trouble Michigan's Market</a>
<h3 class="wp-block-heading">Lawmakers Concerned Over Road Safety</h3>
However, this economic boom is not without its challenges, as increased sales have prompted concerns among state lawmakers about road safety. A bill is under consideration that <a href="https://www.benzinga.com/markets/cannabis/24/07/40084282/ohio-approves-34-dispensaries-as-recreational-sales-near-new-cannabis-dui-testing-bill-controver">would permit law enforcement to conduct oral fluid tests</a> to check for drug impairment in drivers. Yet, research from UC Davis indicates that the presence of THC in bodily fluids <a href="https://www.benzinga.com/markets/cannabis/24/04/38134128/detection-of-cannabis-in-bodily-fluids-not-correlated-with-driving-impairment-new-review-shows">does not correlate with actual driving impairment</a>, challenging the basis of such legislative measures.
As the debate on safety measures unfolds, Ohio&#8217;s adult-use cannabis market remains poised for continued growth and sustained consumer engagement.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/08/40582981/cannabis-careers-in-ohio-attracting-gen-x-millennials-amid-legalizations-economic-boom">Cannabis Careers In Ohio Attracting Gen X, Millennials Amid Legalization&#8217;s Economic Boom</a></li>
</ul>
Image generated with AI tools.

ACRHF

THE CANNABIST CO HLDG by THE CANNABIST COMPANY HOLDINGS INC.

CBSTF

Ohio's Cannabis Sales Reach $44M As New Customers Just Keep Coming And Demand Is Not Slowing

The cannabis market is abuzz following former President Donald Trump&#8217;s recent comments supporting cannabis legalization in Florida.&nbsp;
During a podcast interview, Trump <a href="https://www.benzinga.com/markets/cannabis/24/09/40697992/trump-talks-legal-weed-on-lex-fridman-podcast-we-can-live-with-the-marijuana">backed the state&#8217;s recreational cannabis initiative </a>and emphasized the need for a lawful and regulated framework.&nbsp;
This comes as Florida prepares to vote on a ballot initiative in November, which could reshape the cannabis landscape.
Get Benzinga&#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you&#8217;re serious about the business, you can&#8217;t afford to miss out.
<h3 class="wp-block-heading">Top Performers And Decliners After Trump&#8217;s Comments On Marijuana </h3>
Stocks in the cannabis sector showed varied reactions on Wednesday, after <a href="https://www.benzinga.com/markets/cannabis/24/09/40677600/harris-campaign-slams-donald-trump-over-cannabis-shift-calls-it-brazen-flip-flop">Trump&#8217;s comments</a>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YOLO#NYSE">YOLO</a>) AdvisorShares Pure Cannabis ETF led the gainers, climbing 3.48% to $3.27, reflecting investor optimism around potential federal changes.&nbsp;
(OTC:<a class="ticker" href="https://www.benzinga.com/stock/CANN#OTC">CANN</a>) Trees Corporation experienced a plunge, down 99.8%, closing at $0.0001. Among the notable losers, (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) Canopy Growth dropped 3.37% to $4.87, and (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRON#NASDAQ">CRON</a>) Cronos Group slipped 1.79% to $2.20.
Other stocks remained relatively stable. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) Tilray Brands fell 1.19%, ending at $1.67, and (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) Aurora Cannabis dipped 1.37% to $5.76.&nbsp;
Meanwhile, (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDL#NASDAQ">SNDL</a>) Sundial Growers climbed 2.53%, closing at $2.00, and (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>) Trulieve Cannabis posted a 3.72% gain to $9.75, reflecting positive sentiment around these companies.
Read Also:&nbsp;<a href="https://www.benzinga.com/markets/cannabis/24/09/40712816/what-trump-learned-about-marijuana-that-desantis-did-not-and-why-the-gop-might-become-weed-frien">What Trump Learned About Marijuana That DeSantis Did Not And Why The GOP Might Become Weed-Friendly</a>
<h3 class="wp-block-heading">Stocks To Watch </h3>
<ul>
<li>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSOS#NYSE">MSOS</a>) AdvisorShares Pure US Cannabis ETF ended the day with a slight decline of 0.31%, closing at $6.48.</li>
<li>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IIPR#NYSE">IIPR</a>) Innovative Industrial Properties, a key player in cannabis real estate, dropped 0.82%, closing at $121.58, showing a more cautious response from investors.&nbsp;</li>
<li>(OTC:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTC">GTBIF</a>) Green Thumb Industries posted a modest gain of 0.67%, closing at $9.83, indicating optimism.&nbsp;</li>
<li>(OTC:<a class="ticker" href="https://www.benzinga.com/stock/MJNA#OTC">MJNA</a>) Medical Marijuana Inc. surged 10%, finishing at $0.0011, reflecting renewed interest despite its low price point.</li>
</ul>
Read Next:&nbsp;<a href="https://www.benzinga.com/markets/cannabis/24/09/40713542/2024-election-cannabis-swing-state-voters-back-legalization-new-poll-reveals">2024 Election &amp; Cannabis: Swing State Voters Back Legalization, New Poll Reveals</a>

Small Cap Analysis

Trump's Marijuana Support Could Ignite Stock Surge – Are You Positioned To Benefit?

Trulieve Cannabis (TSE:TRUL) has released an update. Trulieve Cannabis Corp., a leading U.S. cannabis company, has announced its participation in u...

Trulieve Cannabis Engages Investors at Key Conferences

Trulieve Cannabis (TSE:TRUL) has released an update. Trulieve Cannabis Corp. announces the opening of a new medical cannabis dispensary in Lake Wor...

Trulieve Launches New Florida Dispensary with Celebrations

Trulieve: Regulatory Developments And Growth Acceleration Could Trigger Significant Upside

Trulieve Is Not A Good Cannabis Stock To Own

Trulieve Cannabis (TSE:TRUL) has released an update. Trulieve Cannabis Corp. is expanding its reach by opening a new medical cannabis dispensary in...

Trulieve Debuts New Florida Medical Cannabis Dispensary

Why Cannabis Is Still An Excellent Long-Term Investment Opportunity

Colorado cannabis tax revenue seen declining as marijuana tourism subsides

Pennsylvania voters in key districts support recreational cannabis legalization

Trulieve Cannabis (TSE:TRUL) has released an update. Trulieve Cannabis Corp. has partnered with Black Buddha Cannabis to introduce a line of premiu...

Trulieve Debuts Black Buddha Cannabis in Key Markets

Democratic congressmen pressure DEA, DOJ to reclassify marijuana

ACRDF

AYWWF

GHBWF

GLASF

GRAM

GRAMW

MAPS

MAPSW

PLNH

VEXTF

VREOF

Press Releases

Trulieve to Open Medical Cannabis Dispensary in Orlando, Florida

Trulieve Announces Partnership with Professional Pickleball Association and Major League Pickleball

Trulieve Employee Training Program Earns Gold Award for Excellence

Trulieve to Open Florida Medical Cannabis Dispensaries in Cocoa, Miramar Beach, Niceville, and Tampa

Trulieve Opens Relocated Dispensary in Tucson, Arizona

Trulieve to Open Medical Cannabis Dispensary in Clearwater, Florida

Trulieve Announces Upcoming Event Participation

Trulieve to Open Medical Cannabis Dispensary in Lake Worth, Florida

Trulieve to Open Medical Cannabis Dispensary in Hudson, Florida

Trulieve Partners with Black Buddha Cannabis to Launch Premium Products in Arizona and Pennsylvania

Needham

Roth MKM

Seaport Global

Wedbush

Cantor Fitzgerald

2024年第2四半期の大部分の大麻企業の財務業績が出揃い、その結果から興味深いトレンドが浮かび上がってきた。その1つが、米国のマルチステート・オペレーター（MSO）が供給チェーンにおけるコストと効率を改善しているという点だ。
MSOが風雲急を告げてきたことは驚くべきことではなく、かつその回復力が示されてきたのも理解できる。これまで低い卸売価格という圧力に直面し、小売業界での競争の激化と追加の課税に面してきたが、これらの大半の企業は、そのコスト業績を維持し、あるいはいくつかのケースでは改善することに成功してきたのだから。
<h3 class="wp-block-heading">財務詳細</h3>
バリディアン（Viridian）の<a href="https://dealtracker.viridianca.com/chart-of-the-week/">データ分析</a>によると、トップ8のMSOのうち6社の売上高に対する売上原価（COGS）の割合が昨年と比較して減少した。この削減は、これらの企業が課題に直面しながらも生産コストをより効率的に管理していることを示している。比較の対象には、Green Thumb Industries（OTC：<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTC">GTBIF</a>）、Curaleaf（OTC：<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>）、Trulieve（CSE：<a class="ticker" href="https://www.benzinga.com/stock/TRUL#CSE">TRUL</a>）（OTCQX：<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTCQX">TCNNF</a>）、Verano（OTC：<a class="ticker" href="https://www.benzinga.com/stock/VRNOF#OTC">VRNOF</a>）、Cresco Labs（OTC：<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>）、Terrascend（OTC：<a class="ticker" href="https://www.benzinga.com/stock/TRSSF#OTC">TRSSF</a>）、AYR（OTC：<a class="ticker" href="https://www.benzinga.com/stock/AYRWF#OTC">AYRWF</a>）およびAscend Wellness（OTC：<a class="ticker" href="https://www.benzinga.com/stock/AAWH#OTC">AAWH</a>） が含まれる。ただし、AYRとTerrAscendはCOGSが増加した。これは、彼らが他の企業よりもより大きな運用上の課題に直面していることを示している。
さらに、このうちの6社は、2024年第2四半期における2023年第2四半期との比較で、売上高に対する売上、一般および管理（SG&amp;A）費用が低下した。この傾向は、これらの企業が自分たちのベルトを締め直し、支出についてより規律あるものになり、供給チェーンにおいて効率的に動くことを反映している。売上費用の削減は市場状況を反映したものとみられる。オハイオ州とニューヨーク州に新しいマーケットが拡大するにつれて、これらの企業は売上の増加を期待しており、それによって年の後半にはさらに財務業績が向上するはずだ。
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" class="wp-image-490763" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/12160625/unnamed-2.png" sizes="(max-width: 630px) 100vw, 630px" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/12160625/unnamed-2.png 630w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/12160625/unnamed-2-300x194.png 300w" alt="" width="630" height="407" /></figure>
関連記事: <a href="https://www.benzinga.com/markets/cannabis/24/07/39806043/cannabis-stocks-canadian-companies-outperformed-american-counterparts-last-week">大麻株：先週、カナダ企業の方が米国企業をアウトパフォーム</a>
<h3 class="wp-block-heading">MSOと大麻業界における役割の理解</h3>
MSOは複数の州にわたる栽培、加工、小売施設を管理する会社であり、米国の独自の法的枠組みのために同国の大麻市場においてさらに重要なプレーヤーになっている。
大麻が連邦レベルで未だに違法とされているため、ビジネスは州ごとの規制、法則および<a href="https://www.benzinga.com/markets/cannabis/24/08/40176980/state-by-state-price-of-weed-across-the-u-s-in-august-2024">価格</a>といった複雑な規制網を航行せねばならない。MSOはこのような課題を処理するために設計されており、それによって彼らは異なる法律を守りながら、州をまたいでの業務展開を可能にしているのだ。この戦略により、MSOは市場拡大に伴う経済規模の利点を活かし、コストを引き下げ、効率を向上させることができる。ただし、州ごとの規制を遵守することが重要であるため、それによって大きなコストが生じてしまう。
最新のQ2の報告書は、大半のMSOがコスト削減に焦点を当てていることを示唆している。大麻の<a href="https://www.benzinga.com/markets/cannabis/24/07/39892433/dea-rescheduling-of-cannabis-could-create-over-50-000-jobs-industry-group-notes-in-public-commen">スケジューリングの可能性</a>があれば、これは全体の<a href="https://www.benzinga.com/markets/cannabis/24/05/38885460/finally-tax-refunds-these-cannabis-companies-will-get-the-most-money-back-if-rescheduling-happen">税制負担を削減する</a>ことによって、それによってそれらの財務業績を大幅に向上させる可能性がある。
<ul>
<li>次を読む: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/06/39514459/u-s-dollar-soars-how-does-this-threaten-your-cannabis-investments-confidential-insi">米ドルが急騰：これがあなたの大麻投資に脅威を与える理由、機密情報の洞察</a></li>
</ul>
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/cannabis-conference/"><img loading="lazy" decoding="async" class="wp-image-490829" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/12164248/CCC-Oct-24-Banner-1-37.gif" alt="" width="970" height="250" /></a></figure>

令は効率的な運営者の市場占有率の増加と持続可能なプラットフォーム構築を輝かせるだろう。第２四半期の収益を見越して、Zuanic &amp; Associatesのシニアアナリスト、Pablo Zuanic氏は、大麻市場傾向について概要を提供した。
Zuanic氏は、連邦の改革期待、<a href="https://www.benzinga.com/markets/cannabis/24/06/39560744/irs-confirms-no-federal-tax-deductions-for-marijuana-businesses-until-rescheduling-is-finalized"> 280Eに関するIRSのニュース</a>、借り換えの可能性、M&amp;A戦略が感情の主要な推進要因となると強調している。
<h3>州の業績ハイライト</h3>
<ul>
<li><a href="https://www.benzinga.com/stock/TCNNF#OTC">フロリダ</a>：ペースの鈍化と価格のデフレにもかかわらず、フロリダの医療大麻販売は2四半期に4億7900万ドル(約530億円)に達し、四半期対四半期でわずか2％の減少率だった。この州で最も多くの店舗を持つのは、Trulieve（OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>）で142店、次いでVerano（OTC:<a class="ticker" href="https://www.benzinga.com/stock/VRNOF#OTC">VRNOF</a>）で77店である。</li>
<li><a href="https://www.benzinga.com/topic/illinois-cannabis">イリノイ</a>：2四半期に5億5000万ドルの販売を記録し、四半期対四半期で2％の増加を示したものの、1人あたりの消費額がミシガン州の333ドルに比べて158ドルとなり、 この市場は低調な成績を収めた。この州では、Ascend（OTC:<a class="ticker" href="https://www.benzinga.com/stock/AAWH#OTC">AAWH</a>）、Curaleaf（OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>）、Verano、Cresco（OTC:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>）、Green Thumb（OTC:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTC">GTBIF</a>）がそれぞれ10店舗を運営している。</li>
<li><a href="https://www.benzinga.com/topic/pennsylvania-cannabis">ペンシルベニア</a>：2四半期に4億2600万ドルの売り上げを記録し、前年比で11％の増加を示した。ペンシルベニア州では、1店舗あたりの年間売上高が940万ドルに達するなど、健全な小売業の経済活動が繰り広げられている。この州で最も多くの店舗を運営するのは、Veranoで18店である。</li>
<li><a href="https://www.benzinga.com/topic/arizona-cannabis">アリゾナ</a>：2四半期に3億1000万ドルの売り上げを記録し、四半期対四半期で7％の減少を示した。この州では、栽培業者と小売業者の両方に影響を及ぼすデフレが続いている。この州で最も多くの店舗を運営するのはTrulieve（21店）とCuraleaf（16店）だ。</li>
<li><a href="https://www.benzinga.com/topic/maryland-cannabis">メリーランド</a>：2024年の第2四半期には、23年7月1日からのリクリエーショナルの売り上げを含めて、合計2億8400万ドル（約3,120億円）の売り上げを記録し、前年同期比で130％増となった。この州では、複数の店舗を運営する企業として、CuraleafとGreen Thumbが注目されている。</li>
<li><a href="https://www.benzinga.com/topic/new-jersey-cannabis">ニュージャージー</a>：1四半期の売り上げは2億2500万ドルであり、伸びているものの、1人あたりの消費額は低調である。この州では、複数の店舗を運営する企業として、Curaleaf、Verano、Green Thumbが注目されている。</li>
<li><a href="https://www.benzinga.com/topic/ohio-cannabis">オハイオ</a>：リクリエーショナルの販売が始まり、2四半期には1億2000万ドル（約131億円）の医療大麻の売り上げを記録した。価格は上昇しているものの、Cresco、Green Thumb、Columbia Care（OTC:<a class="ticker" href="https://www.benzinga.com/stock/CCHWF#OTC">CCHWF</a>）などの企業が、この州での大事な運営者となっている。今年8月の時点でオハイオ州では、医療大麻のリクリエーショナル販売が始まった。</li>
<li><a href="https://www.benzinga.com/topic/michigan-cannabis">ミシガン</a>：2四半期には8億3700万ドル（約9,210億円）の売り上げを記録し、四半期対四半期で6％、前年同期比で11％増となった。ミシガン州は、1人あたりの消費額が333ドルという数字で、大麻業界の最大の市場となっている。この州の中で、最も多くの店舗を運営するのは、Green Peak InnovationsとLume Cannabis Co.である。</li>
</ul>
次の一歩:<a href="https://www.benzinga.com/markets/cannabis/24/08/40139356/cannabis-sales-in-u-s-hit-32b-in-june-key-drivers-behind-all-time-record-revealed"> 6月における米国の大麻販売は320億ドルに達し、過去最高の記録を出した背景にある、重要な要因</a>
会議の概要

ペンシルベニア州が最近承認した予算には、大麻企業であるJushi Holdings（OTC：<a class="ticker" href="https://www.benzinga.com/stock/JUSHF#OTC">JUSHF</a>）およびTILT Holdings（OTC：<a class="ticker" href="https://www.benzinga.com/stock/TILT#OTC">TILT</a>）のような企業にとって大きな打撃を与える、大麻の娯楽利用の合法化が除外されています。
ジョシュ・シャピロ知事が支援したこの動きに対し、民主党と共和党に分かれた州議会からは<a href="https://www.spotlightpa.org/news/2024/06/pennsylvania-marijuana-recreational-legislature-passage-budget-josh-shapiro/">反対</a>が出てしまいました。規制に関する合意については、民主党が支配する州下院で合意に達しようとする一方で、大麻の娯楽利用の合法化に反対する共和党が支配する州上院は合意に達しませんでした。
新しい<a href="https://www.pa.gov/en/governor/newsroom/2024-press-releases/governor-shapiro-signs-bipartisan-2024-25-budget--investing-in-e.html">予算</a>は幅広い経済的および社会的投資に焦点を当てていますが、娯楽利用の大麻についての規定は除外しています。主な投資先は、K-12公共教育のための11.1億ドル、企業の誘致のためのサイト開発のための5億ドル、および家庭およびコミュニティを対象としたサービスのための3億5480万ドルが含まれています。
<h3>遅れの中でのJushiとTILTの戦略的動向</h3>
Jushi Holdings（OTCQB）とTILT Holdings（OTCQB）は、ペンシルベニア州での医療大麻の販売から娯楽大麻の販売への移行によって成長が促進されると予測し、大規模な投資を行っています。
Jushiの現在の企業価値は過小評価されていると見なされ、規制の透明性が与えられれば大きな上昇余力があるということを示唆しています。 Zuanic＆AssociatesのシニアアナリストPablo Zuanic氏は、「ペンシルベニア州が娯楽大麻の販売を開始すれば、Jushiの時価総額は250％以上急増する可能性がある」と述べています。
一方、TILT HoldingsはStandard Farmsを運営しており、ペンシルベニア州での事業拡大のために1050万ドルの資金調達契約を締結しました。 これらの資金は、保健省（Department of Health）の許可を受けたディスペンサリーの構築に充てられます。
「ペンシルベニア州が、TILTのStandard Farmsのような小規模な独立系栽培業者がこの新興の市場で競争できるように、我々は賞賛します」と、TILTのCEOであるTim Conder氏は<a href="https://www.benzinga.com/markets/cannabis/24/05/38741310/tilt-holdings-bold-financing-move-how-this-cannabis-companys-escalating-interest-rates-impact-it">述べています</a>。
しかし予想される娯楽市場がないとすると、6か月後にかなり高騰する拡大ローンの金利がTILTの財務モデルに圧迫を与える可能性があります。
<h3>ティム・シーモア氏は州による大麻の合法化をどう見るか</h3>
CNBS Amplify Seymour Cannabis ETF（NYSE：<a class="ticker" href="https://www.benzinga.com/stock/CNBS#NYSE">CNBS</a>）のポートフォリオマネージャーであるTim Seymour氏は、連邦政府の変化よりも州レベルでの大麻の合法化の重要性を強調しました。 「大麻セクターにおける実際の経済は、成長している消費者基盤向けに積極的に製品を販売している企業によって推進されています」と、Seymour氏は<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/06/39344068/not-dc-but-the-states-tim-seymour-discusses-how-red-states-could-catalyze-cannabis-">語りました</a>。
彼は、ペンシルベニア州のような市場が、大麻業界の成長を促進していると指摘し、州レベルの決定が大麻産業の未来にとって重要であることを示唆しています。
関連記事：
<h3>ペンシルベニア州における大麻企業</h3>
JushiとTILTの両社は、ペンシルベニア州の予算における娯楽利用の大麻の除外がもたらす不確実な規制環境に適応しなければなりません。
予算から娯楽利用の大麻が除外されたことは、分かれた州議会での合意形成の複雑さを象徴しています。Seymour氏が指摘したように、「州レベルの法制化は、実際の産業の成長につながる製品を消費者の手に届けるものです」。
Zuanic氏は、「<a href="https://www.benzinga.com/markets/cannabis/24/02/37242307/jushi-holdings-revs-up-unleashing-torque-in-pennsylvania-and-virginias-cannabis-expansion">娯楽利用の大麻が合法化されない</a>場合、Jushi Holdingsは医療大麻市場に制限されることで成長が制約されるだろう」と述べたように、Jushiもまた州の不確実な規制環境に適応しなければなりません。
販売の勢いと利益率の面で競合他社に遅れをとっているにも関わらず、Jushiは業務を合理化し、EBITDAマージンを大幅に改善しています。 Zuanic氏は、12月2024年に支払期日を迎える約6,500万ドルの借金の<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/06/39470114/debt-deadline-looms-how-cannabis-companies-financial-health-could-impact-your-portf">返済の取り組み</a>に加え、Jushiの財務状況は管理可能であると考えています。
<h3>予算承認後の市場動向</h3>
2024年7月15日（月）、午後12時過ぎ、Jushi Holdings（NYSE：<a class="ticker" href="https://www.benzinga.com/stock/JUSHF#NYSE">JUSHF</a>）の株価は0.592ドルで、2.8449％下落し、投資家の信頼が低下していることを示しています。取引高は8339株で、市場活動は抑制的であることを示しています。時価総額は約1億1600万ドルであり、大麻セクターの中では比較的小さな企業です。
TILT Holdingsの株価は0.02211ドルで、10.55％上昇し、これは投資家からのポジティブな評価か、または最近のニュースへの反応であると考えられます。株価は6,150で、これは中規模の取引高で、時価総額は約850万ドルであり、大麻セクターの中でマイクロキャップ株式として位置づけられています。
これらは、ペンシルベニア州で<a href="https://www.benzinga.com/topic/pennsylvania-cannabis">運営している最も重要なMSO</a>の一部です。
<ul>
<li>Curaleaf Holdings（OTC：<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>）</li>
<li>Trulieve Cannabis（OTC：<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>）</li>
<li>Cresco Labs（OTC：<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>）</li>
<li>Green Thumb Industries（OTC：<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTC">GTBIF</a>）</li>
<li>Ayr Wellness（OTC：<a class="ticker" href="https://www.benzinga.com/stock/AYRWF#OTC">AYRWF</a>）</li>
<li>Verano Holdings（OTC：<a class="ticker" href="https://www.benzinga.com/stock/VRNOF#OTC">VRNOF</a>）</li>
<li>TerrAscend（OTC：<a class="ticker" href="https://www.benzinga.com/stock/TRSSF#OTC">TRSSF</a>）</li>
<li>The Cannabist Co.（OTC：<a class="ticker" href="https://www.benzinga.com/stock/CCHWF#OTC">CCHWF</a>）</li>
</ul>
次の一手：　
これらの問題については、10月8日から9日まで開催されるベンジンガ・カンナビス・キャピタル・カンファレンス（Benzinga Cannabis Capital Conference）で大いに議論されることでしょう。大麻業界の将来における投資の意味について更に多くの見識を得るために、ぜひ私たちにご参加ください。このカンファレンスで、大手企業のトップエグゼクティブ、投資家、提唱者、立法者の皆様の素晴らしいご意見をお聞きになりませんか。　<a href="https://www.eventbrite.com/e/benzinga-capital-conference-cannabis-fall-2024-tickets-858948065787?aff=oddtdtcreator" target="_blank" rel="noreferrer noopener">チケットをお求めください</a>。
写真：AIによる生成画像。

最近、ビーコン・証券がフロリダ州の大麻産業に関する最新のレポートで、選挙への寄付、政治的支援、市場競争、財務予測の情報が提供された。
<h3>リバタリアン党の支援</h3>
レポートによると、フロリダ州のリバタリアン党は成人のマリファナ使用を合法化する措置を公式に支持したという。この支持は、党が大麻の使用に関して個人の自由を主張しているため、選挙民の立場に変化を示す可能性がある。様々な政党からの増加する政治的支援は、大麻の合法化に対する受け入れが増していることを示している。
<h3>麻業界の政治的寄付</h3>
『CBSニュース』によると、フロリダの共和党にヘンプの幹部が500万ドルの寄付を約束したと報じられた。この出来事が起きたのは、デサンティス州知事がヘンプ産業に悪影響を及ぼすことになる法案を拒否した後のことだ。
レポートによると、この拒否は戦略的な動きと見なされ、グループSave Florida HempからのWhatsAppメッセージでは、11月の投票用紙に大麻の成人利用合法化に反対するデサンティス州知事とヘンプ業界が<a href="https://www.benzinga.com/markets/cannabis/24/07/39760907/ron-desantis-floridas-gop-and-hemp-industry-pile-on-to-defeat-marijuana-legalization">一致した</a>と示唆しているという。
続きを読む:<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/06/39344068/not-dc-but-the-states-tim-seymour-discusses-how-red-states-could-catalyze-cannabis-">Ron DeSantis, Florida&#8217;s GOP And Hemp Industry Pile On To Defeat Marijuana Legalization</a>
<h3>新しいマリファナ店、シェア、競争</h3>
140店舗を展開し市場を主導するTrulieve Cannabis（OTC：<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>）は、最近グルフ・ブリーズに新しい大麻店をオープンし続けている。 Verano Holdings（77店舗）は市場での存在感を高めることを目指している。
Trulieve、Curaleaf（OTC：<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>）、Verano（OTC：<a class="ticker" href="https://www.benzinga.com/stock/VRNOF#OTC">VRNOF</a>）などの主要プレイヤー間の競争が激化しており、各企業はそれぞれ市場シェアを拡大するための戦略を採用している。
Beaconのレポートによると、フロリダ州保健省のデータによると、これらの企業は花およびオイルベースの製品の<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38470560/landing-in-floridas-cannabis-market-legal-adult-use-marijuana-could-yield-874m-in-2">大幅な売上</a>を記録している。
<h3>財務業績</h3>
Verano HoldingsとCuraleaf Holdingsは8月7日に第2四半期の業績を発表する見込みであり、Veranoは売上高と調整後EBITDAが予測の低い方になると予測している。
これらの企業の運用キャッシュフローおよびフリーキャッシュフローは、280E税法の再スケジュール化と撤廃によって大幅に増加すると予想されている。
次を読む：<a href="https://www.benzinga.com/markets/cannabis/24/06/39561566/will-bidens-shaky-debate-performance-affect-cannabis-reform-how-a-trump-return-could-reshape-mar">トランプ政権の復帰がマリファナ政策をどのように再構築するか</a>
これらの問題は、今年10月8日～9日にシカゴで開催されるBenzinga Cannabis Capital Conferenceで話題になることだろう。この会議にご参加いただくと、大麻業界への投資の未来を考える上で、大麻合法化の流れが意味することについて、より深く理解することができます。トップエグゼクティブ、投資家、支持者、および政策立案者からの直接の話もお楽しみください。 <a href="https://www.eventbrite.com/e/benzinga-capital-conference-cannabis-fall-2024-tickets-858948065787?aff=oddtdtcreator" target="_blank" rel="noreferrer noopener">このリンク</a>を<a href="https://www.eventbrite.com/e/benzinga-capital-conference-cannabis-fall-2024-tickets-858948065787?aff=oddtdtcreator" target="_blank" rel="noreferrer noopener">クリックして</a>、チケットの価格が上がる前にお求めください。
写真：AIによる生成画像

ビーコン・証券　リバタリアン党の支援を公式に支持

フロリダ州の大麻嗜好の<a href="https://www.benzinga.com/markets/cannabis/24/04/38034138/florida-supreme-court-approves-cannabis-legalization-proposal-for-november-election-in-blow-to-d" target="_blank" rel="noreferrer noopener">合法化</a>と中絶へのアクセスに関する憲法改正の最中、ロン・デサンティス（Ron DeSantis）知事が大きな資金調達不利に直面している。デサンティス知事が最近作ったこのフロリダ自由基金は、これら2つの改正を打ち負かすという宣言をしているが、これまでのところたったの10000ドルしか調達できておらず、それも<a href="https://www.benzinga.com/markets/cannabis/24/04/38034138/florida-supreme-court-approves-cannabis-legalization-proposal-for-november-election-in-blow-to-d">大麻改正</a>の支持者が集めた何百万ドルと比べると額が小さい。
このイニシアチブを主導する<a href="https://www.benzinga.com/markets/cannabis/24/04/38313915/cannabis-in-florida-the-bellamy-brothers-tell-trulieve-ceo-we-rolled-a-fat-one-when-legalization" target="_blank" rel="noreferrer noopener">Smart &amp; Safe Florida</a>委員会は、6月10日のキャンペーン書類によると、6000万ドル以上を調達したと報告している。6月21日に終了した5週間の資金調達活動で、デサンティス知事の自由基金は10000ドルを調達したとの<a href="https://floridapolitics.com/archives/682069-ron-desantis-florida-freedom-fund-off-to-slow-fundraising-start/">報告</a>もある（Florida Politicsより）。どちらの改正も<a href="https://www.benzinga.com/topic/2024-election">2024年11月の</a>大統領選挙で決定される予定だ。フロリダを拠点とする<a href="https://www.benzinga.com/markets/cannabis/23/10/35206042/trulieve-donates-500k-to-floridas-marijuana-legalization-ballot-initiative">Trulieve</a>（OTCQX：TCNNF）は、この法案を投票所に載せるため4000万ドル以上を費やしているとされている。
デサンティスの大麻合法化イニシアチブ（改正3として知られている）に対する批判の一環として、彼は合法大麻はフロリダがサンフランシスコやシカゴのような都市に変わる1つの出口だ、としている。彼は6月中旬の記者会見で、フロリダが合法化すれば人々は「小学校に20本のジョイントを持って行けるようになるだろう」と述べている。
&#8220;我々は、大麻をどこでも、タバコのように吸ってもいいよ、というようなことはしないために、この改正3を打ち負かすために関心を持っている利害関係者と協力している。フロリダをサンフランシスコやシカゴ、あるいはいくつかの他の場所に変えることになるからだ。&#8221;とデサンティス知事は<a href="https://www.benzinga.com/markets/cannabis/24/06/39492507/desantis-says-cannabis-legalization-amendment-will-protect-weed-rights-better-than-1st-2nd-amend">述べている</a>。「我々はすでに医療大麻を持っている。ただし、我々は街を清潔に保たなければならない。すべての都市が大麻のような香りを漂わせるわけにはいかないのです」
これにもかかわらず、最近の<a href="https://www.benzinga.com/markets/cannabis/24/06/39261393/trump-holds-4-point-edge-over-biden-in-florida-rematch-can-cannabis-tilt-the-scale-as-majority-s" target="_blank" rel="noreferrer noopener">フォックスニュースの世論調査</a>によると、フロリダ州民の69％が中絶へのアクセスイニシアチブを支持し、66％が大人の使用の合法化を支持しているという結果にもかかわらず、デサンティス知事は大麻に反対している。
関連記事: <a href="https://www.benzinga.com/markets/cannabis/24/06/39492507/desantis-says-cannabis-legalization-amendment-will-protect-weed-rights-better-than-1st-2nd-amend">デサンティス知事、大麻合法化の改正は、1・2条修正案よりも大麻の権利を保護する</a>

フロリダ州の大麻改正　支持者が依然優勢な展開に

DEAが大麻を<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38226873/analyst-reacts-to-fda-commish-comments-medical-and-recreational-cannabis-could-have">再スケジュール</a>すると発表し、大麻業界が新しい規制環境に適応する中、最近のViridian Capital Advisorsの報告書によると、企業結合および買収活動（M&amp;A）が大幅に増加する可能性を示唆している。
<h2>ティア1マルチステート企業の利益増</h2>
この分析は、ティア1マルチステート企業（MSO）と小規模企業との間の評価格差の重要な動向を強調しているが、これは3年ぶりの広がりとなっている。
市場価格で並べ替えられたティア1MSOには、Curaleaf Holdings（OTC：<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>）の415億ドル、Green Thumb Industries（OTC：<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTC">GTBIF</a>）の298億ドル、Trulieve Cannabis（OTC：<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>）の210億ドル、Cresco Labs（OTC：<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>）の7.1851億ドルなどの会社が含まれる。
この格差は、<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38386324/whos-winning-in-weed-analyst-looks-at-cannabis-markets-big-players-where-are-the-be">大企業</a>にとってM&amp;Aがますます有利になっていることを意味している。簡単に説明すると、大企業は、それらの市場価値に比べて相対的に低い価格で他の会社を買収することができるため、今後は以前よりも買収を通じて成長できるようになったということだ。
<h3>資本コストのダイナミクスが条件付けを変える</h3>
<a href="https://dealtracker.viridianca.com/chart-of-the-week/">報告書</a>は、資本コストに関する増大する差異についても言及しており、これにより大規模で公開されたティア1MSOが有利に立つようになっている。
したがって、これらの企業は、自社よりも小規模で、しばしば非公開の会社よりも、資金調達する際により低コストでやりくりができるようになった。この金融的レバレッジは、大企業のMSOの取引の交渉力を大幅に変え、彼らがより簡単に取引を成立させたり、終了させたりすることを可能にしている。
Viridianの報告書によると、これらのダイナミクスは、特に市場の長期戦によって疲れ切った小規模な競合他社が、撤退することをますます考える中、業界全体での統合のための堅牢な時期になるとのことだ。
報告書によると、公開企業の株価の上昇と<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38420095/cannabis-companies-gains-u-s-versus-canada-averages-can-be-deceiving-irrational-mar">健全な資金余力</a>を利用して、2024年の下半期と2025年の初めには明白なM&amp;A活動の上昇が予想されている。
<img decoding="async" style="height: 545px; width: 633px;" src="https://www.benzinga.com/files/u503488/viridian_capital_advisors_-_ma.png" alt="viridian_capital_advisors_-_ma.png" />
Viridianのチャートは、2021年上半期における栽培および小売りセクター内でのM&amp;A活動の顕著な減少を示しており、それは緑の縦棒が合計取引価値の減少を示しているからだ。大部分の影響は、MSOの<a href="https://www.benzinga.com/markets/cannabis/24/05/38559933/billions-on-the-move-tracking-market-cap-changes-in-top-cannabis-firms-after-dea-rescheduling-an">ETF価格</a>を示すオレンジ色の線により示されており、またMSOが拡大を追求する代わりに現金を節約するため資本市場が緊縮化したことが影響している。 しかし、報告書は、この動向が近いうちに逆転する可能性があるとの見解を示している。
<h3>取引の株式化</h3>
大手企業は、大麻を事業の一環として日課とすることに対する期待によって、株式価格がゆっくりと上昇する中、新しい資金調達を行う際には自社株を使用する方が有利であると考えるようになってきた。
この傾向は、銀行制度の改革や立法の更新が遅れているため、銀行から現金を得ることが難しく、またより高いコストがかかるためである。その結果、<a href="https://dealtracker.viridianca.com/chart-of-the-week/">報告書</a>では、M&amp;A活動を資金調達する際に、資金よりも株式が優先されるようになっているとのことだ。
<h3>プロのアドバイス</h3>
企業が株式を現金よりも優先してM&amp;Aに利用することにより、その企業の株価が堅調であり、市場条件が好調で、また株価に影響を与える投資家の信頼が高いタイミングであると、株式を利用したM&amp;A活動は最適であるとされている。
ただし、この方法は慎重に扱わないと、株主の株価の希釈を引き起こす可能性がある。この結果、市場は発行が過剰だと認識してしまい、株価が下落する原因となることがあるのだ。新株の発行によって、合計株数が増加し、<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38206489/cannabis-markets-trading-volume-surges-up-292-viridian-capital-highlights-mixed-liq">流動性が</a>向上し、それによって新たな投資家が引きつけられるかもしれないが、株価に影響を与えるリスクもあるのだ。
今読む： <a href="https://www.benzinga.com/markets/cannabis/24/05/38627339/the-cannabis-caregiver-econo[…]-these-workers-deserve-market-access-and-how-states-can-help" target="_blank" rel="noopener noreferrer">大麻介護労働経済：なぜこれらの労働者には市場アクセスが必要であり、州の支援が必要なのか</a>
大麻のM&amp;A活動とその投資機会への影響についてより深く理解しようとする皆様には、10月8日-9日にシカゴで開催される第19回Benzinga Cannabis Capital Conferenceに参加する機会を逃さないようにしてください。 産業の未来を探るために、このイベントには業界のトップエグゼクティブ、投資家、政策立案者、支援者が集結します。 <a href="https://www.benzinga.com/events/cannabis-conference/?UTM_source=article" target="_blank" rel="noopener">こちらのリンク</a>に従ってチケットを購入する前に、チケットを確保してください。

Comments

Trulieve Cannabis

ニュース

最新ニュース Trulieve Cannabis (OTC:TCNNF) 株価情報

月曜日, 8 12, 2024

水曜日, 8 07, 2024

火曜日, 7 16, 2024

月曜日, 7 01, 2024

火曜日, 5 07, 2024

木曜日, 4 18, 2024

ニュース

パートナーシップ

ベンジンガ・グローバル